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ABSTRACT 
Adherence to the post-transplant medical regimen could maximize outcomes in lung 
transplant recipients (LTRs). This dissertation addresses three major gaps in the LTR 
adherence literature: 1) the need to synthesize evidence on adherence to medical regimen, 
2) a lack of evidence concerning longitudinal patterns and correlates of adherence to self-
monitoring, a challenging issue for LTRs, and 3) the need to understand longitudinal 
patterns and correlates of self-care agency (SCA, one’s willingness and ability to perform 
self-care), a potentially important theoretical construct for adherence.  
Study 1. To synthesize the current state of science on adherence in LTRs, a 
systematic review was conducted. Findings indicated that nonadherence rates varied 
greatly across the elements of the regimen and between studies, and could not be 
consistently attributed to any single factor. Effect sizes of interventions designed to 
promote adherence ranged from .05 to .45. There was a weak correlation between 
nonadherence to home spirometry and patient mortality.  
Study 2. To better understand longitudinal patterns and correlates of SCA, a 
trajectory analysis was conducted. Findings revealed 3 patterns for SCA: persistently low, 
persistently moderate, and persistently high. Requiring re-intubation post-transplant 
(p=.043), discharged to a facility rather than home (p=.048), and endorsing a higher 
baseline anxiety level (p=.001) were associated with membership in the persistently low 
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SCA group. Higher anxiety and depression levels were associated with memberships in the 
persistently moderate and persistently low SCA groups over 12-months (ps<.05). 
 Study 3. To advance the field’s understanding of patterns and correlates of 
adherence to self-monitoring, a trajectory analysis was performed. Findings revealed two 
patterns of adherence to self-monitoring: moderately adherent with slow decline and 
persistently nonadherent. Baseline correlates for being persistently nonadherent included 
female gender (p=.035), higher anxiety (p=.008), and lower sense of personal control over 
health (p=.005). Lower physical component scores of quality of life over 12 months were 
associated with membership in the persistently nonadherent group (p=.004). 
 This dissertation points to the need for more strategies to promote and sustain 
adherence over time in LTRs. Future interventions should target reducing psychological 
distress and reinforcing the sense of control over one’s health in LTRs.  
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1.0  INTRODUCTION 
Lung transplantation is one of the most effective treatments for extending survival and 
improving quality of life for persons with end-stage lung diseases (Kugler et al., 2005; 
Rodrigue, Baz, Kanasky, & MacNaughton, 2005; Vasiliadis, Collet, & Poirier, 2006). 
While the first year survival rate among lung transplant recipients (LTRs) is similar to 
recipients of other solid organ transplants (International Society for Heart & Lung 
Transplantation, 2015), the 5-year survival rate for LTRs is much lower due to higher risks 
of complications, such as graft rejection and infection (Studer, Levy, McNeil, & Orens, 
2004; Yusen et al., 2014). For example, the first year survival rate for LTRs is about 80%, 
compared to 85% for heart transplant recipients (International Society for Heart & Lung 
Transplantation, 2015; Yusen et al., 2014). Yet, for LTRs this rate is only 65% for 3-year 
survival and 53% for 5-year survival. In contrast, for heart transplant recipients, 5-year 
survival is around 70% (International Society for Heart & Lung Transplantation, 2015; 
Yusen et al., 2014). 
To allow for early detection and prompt intervention on post-transplant 
complications, LTRs are expected to adhere to a complex lifelong medical regimen (De 
Geest et al., 2005; DeVito Dabbs et al., 2009; Dew et al., 2007; Dew, DiMartini, et al., 
2008). The science of adherence to the medical regimen in the context of lung 
transplantation is a continuously expanding area with much potential to positively impact 
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post-transplant care for LTRs. However, several gaps in our understanding remain. As 
described in what follows, this dissertation project contributes to the science of adherence 
behaviors among LTRs using three complementary approaches: 1) a systematic review, 2) 
an analysis of self-care agency, a critical theoretical concept thought to be of importance 
to adherence behaviors, and 3) an analysis focusing on a particularly challenging area of 
adherence for LTRs, which is adherence to self-monitoring. 
Study 1. While there is a growing body of literature on adherence behaviors among 
LTRs, translating this body of research to practice requires a systematic examination of the 
evidence. To date, one meta-analysis and two reviews have examined prevalence and risk 
factors of nonadherence among adult heart and lung transplant recipients (De Geest et al., 
2005; Dew et al., 2007; Korb-Savoldelli et al., 2010). However, the number of studies 
pertaining to LTRs was few, thus limiting the ability to draw conclusions about adherence 
after lung transplantation. While LTRs and heart transplant recipients may share some 
similarities in post-transplant care given that both belong to the cardiothoracic transplant 
groups, there are unique challenges and barriers for LTRs to be adherent because of greater 
complexity of post-transplant medical regimen and higher risks for infection and graft 
rejection. Without a systematic review of the up-to-date evidence, it is challenging for 
clinicians to apply research evidence into their care for LTRs. Therefore, the first study of 
this dissertation project aimed to systematically review the evidence regarding the 1) 
prevalence of nonadherence; 2) risk factors for nonadherence; 3) impact of interventions 
for promoting adherence; and 4) outcomes of nonadherence, among LTRs (see Chapter 2). 
While this review is a distinct study within the dissertation project, it also provides 
a foundation for the other two studies in this dissertation, both offering additional 
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justification for conducting those studies and informing the discussion of implications from 
their findings. I will provide such connections at the beginning of manuscripts 2 and 3 to 
explicitly describe how they complement this one. 
Study 2. The second study of this dissertation project focused on a potentially 
important theoretical construct for adherence in LTRs, which is self-care agency (SCA). 
SCA is defined as one’s willingness and ability to engage in self-care behaviors (Orem, 
2001). The rationale for focusing on SCA was that this concept has emerged in research on 
other chronic diseases management as an important theoretical construct to be considered 
in interventions to promote adherence to medical regimen (Baker & Denyes, 2008; Dale, 
Söderhamn, & Söderhamn, 2012; Wang, Lau, Loo, Chow, & Thompson, 2014; Wong, Ip, 
Choi, & Lam, 2015), but it has received little attention in the context of LTRs. To date, 
only one study has described levels of SCA and examined its correlates among LTRs prior 
to discharge from their transplant surgery (DeVito Dabbs et al., 2013). DeVito Dabbs and 
colleagues (2013) found that LTRs reported higher levels of SCA than patients with other 
chronic diseases and suggested one possible explanation was that prior to discharge when 
SCA was assessed, LTRs might be overly confident about their capability to perform self-
care behaviors at home. Thus, DeVito Dabbs and colleagues (2013) called for future work 
to explore the longitudinal patterns of SCA among LTRs. To address this gap, study 2 of 
this dissertation aimed to 1) describe distinct patterns of SCA and 2) identify correlates of 
SCA among LTRs over the first 12-months post-hospital discharge after transplant (see 
Chapter 3). 
Study 3. One key issue in the field of adherence is the need for advanced 
approaches to understand longitudinal adherence patterns within individuals and to identify 
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groups of individuals with similar patterns (Dunbar-Jacob & Sereika, 2001). While this 
issue is beginning to receive attention with respect to medication taking among other 
chronic disease populations (Gonzalez et al., 2007; Greenley et al., 2015; Gueorguieva, 
Wu, Krystal, Donovan, & O’Malley, 2013), little is known of longitudinal patterns of 
adherence in the context of LTRs. The need to understand longitudinal patterns of 
adherence in LTRs is especially important for self-monitoring, a critical aspect of the post-
transplant medical regimen that has been reported to be particularly difficult for LTRs 
(Dew, DiMartini, et al., 2008). Self-monitoring has been defined as “an awareness of 
symptoms or bodily sensations that is enhanced through periodic measurements, 
recordings and observations to provide information for improved self-management” 
(Wilde & Garvin, 2007, p. 343). In the case of LTRs, self-monitoring is expected to be 
performed daily and encompasses monitoring a variety of health indicators, including lung 
function, vital signs and a range of respiratory symptoms (Kugler et al., 2009; Kugler et 
al., 2010; Lindgren, Snyder, Sabati, Adam, & Finkelstein, 2002; Sabati, Snyder, Edin-
Stibbe, Lindgren, & Finkelstein, 2001; Yoon et al., 2008). Adhering to these self-
monitoring activities helps LTRs detect early signs and symptoms of rejection or infection 
and seek prompt treatment thereby minimizing if not preventing poor health outcomes 
(DeVito Dabbs et al., 2009; Finkelstein et al., 1999; Finkelstein et al., 2012; Kugler et al., 
2009; Yoon et al., 2008). Despite evidence that rates of nonadherence to self-monitoring 
of lung-function are high, reaching up to 62.0% at 2-years post-transplant (Dew, DiMartini, 
et al., 2008; Kugler et al., 2010; Lindgren et al., 2002; Morlion, Knoop, Paiva, & Estenne, 
2002; Sabati et al., 2001; Teichman, Burker, Weiner, & Egan, 2000), little is known about 
the patterns and correlates of adherence to self-monitoring among LTRs over time. 
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Therefore, the third aim of this dissertation study was to 1) describe distinct patterns of 
adherence to self-monitoring and 2) identify correlates of adherence to self-monitoring 
among LTRs over the first 12-months post-hospital discharge after transplant. We analyzed 
the same dataset as Study 2 and reported corresponding findings in the third manuscript of 
this dissertation (see Chapter 4).  
The direct contribution of this dissertation project is to 1) provide an overview of 
current state of science regarding the adherence behaviors among LTRs and 2) expand the 
field’s understanding of patterns and correlates of SCA and adherence to self-monitoring 
after lung transplantation. The knowledge gained in this study could be used to inform the 
development of behavioral interventions aimed at promoting self-monitoring behaviors 
after lung transplantation. The evidence obtained in this dissertation may also contribute to 
the growing body of literature on adherence to self-monitoring more generally among 
patients with chronic illnesses since self-monitoring is an essential component of self-
management across a broad range of lung and other diseases. In line with recent calls at 
the national level (Ohno-Machado, 2014), this dissertation also served as an exemplar of 
using advanced statistical techniques to make full use of an existing dataset. Such 
approaches hold the potential to clarify some of the most challenging questions faced by 
behavioral researchers in nursing science.  
The methods (including study design, sample and setting, measures, statistical 
analysis) for each study are described in details in each manuscript (see Chapter 2, 3, and 
4). Following the three manuscripts, an integrative summary of dissertation findings is 
provided.   
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2.0  MANUSCRIPT 1: NONADHERENCE TO THE MEDICAL REGIMEN 
AFTER LUNG TRANSPLANTATION: A SYSTEMATIC REVIEW 
INTRODUCTION TO MANUSCRIPT 1 
This chapter reports findings regarding the first specific aim of the dissertation work: 
Aim 1: Systematically review the evidence regarding the 1) prevalence of nonadherence; 
2) risk factors for nonadherence; 3) impact of interventions for promoting adherence; and 
4) outcomes of nonadherence, among LTRs.  
While the science of adherence to the medical regimen in LTRs has continuously 
expanded over the last few years, there is a lack of a systematic examination of published 
evidence on adherence after lung transplant. Without a systematic review, it is challenging 
for clinicians to translate evidence into their care of LTRs. Therefore, the first study of this 
dissertation aimed to provide an overview of the current state of science on adherence to 
the medical regimen in LTRs. Instead of focusing on one particular element of post-
transplant medical regimen, this review examined the broad landscape of the LTR 
adherence literature by including reports on adherence to any element of the medical 
regimen among LTRs. Following on this brief introduction is the full report of manuscript 
1, titled “Nonadherence to the Medical Regimen after Lung Transplantation: A Systematic 
Review”.  
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2.1 ABSTRACT 
Background: Lung transplant recipients (LTRs) are required to adhere to a lifelong 
complex medical regimen post-transplant. While a growing number of studies have 
explored adherence behaviors among LTRs, translating this body of research to practice 
requires a systematic examination of the evidence. This study aims to systematically review 
evidence regarding 1) the prevalence of post-transplant regimen nonadherence (NA); 2) 
risk factors for NA; 3) impact of interventions for promoting adherence; and 4) transplant-
related clinical outcomes of NA among LTRs.  
Method: Following the PRISMA guideline, a literature search in 5 medical databases was 
conducted using key terms focusing on elements of medical regimen after lung transplant. 
We calculated the NA person-time incidence rates to account for different follow-up 
durations across studies. The effects of interventions and associations between NA and 
clinical outcomes were calculated.   
Results: Thirty articles were included in this review. Together, these articles suggest that 
NA to the medical regimen is prevalent, varies by elements of the regimen, and is not 
consistently associated with any single risk factor. Intervention studies yielded a wide 
range of effect sizes for impact on adherence (correlation coefficients: 0.05-0.45). Articles 
examining the relationship between NA and patient mortality found weak correlations 
ranging from 0.03-0.08. Major limitations across studies were weaknesses in the 
methodologies for measuring NA, varying definitions of NA, lack of a theoretical basis for 
interventions, small sample sizes, and limited follow-up periods.   
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Conclusion: This review underscores the need for rigorous studies of risk factors and 
clinical outcomes of NA in LTRs and for large-scaled randomized controlled trials to 
examine the effects of interventions on adherence in LTRs. 
2.2 INTRODUCTION 
Lung transplantation is one of the most effective treatments for improving quality of life 
for persons with end-stage lung disease (Finlen Copeland, Vock, Pieper, Mark, & Palmer, 
2013; Kugler et al., 2005; Kugler, Tegtbur, et al., 2010; Ortega et al., 2009; Rodrigue et 
al., 2005; Santana, Feeny, Jackson, Weinkauf, & Lien, 2009; Vasiliadis et al., 2006). While 
great success has been made in terms of short-term survival, the long-term survival rate for 
LTRs is less optimal (Lund et al., 2014; Yusen et al., 2014). One reason is that LTRs are 
at a higher risk of developing transplant-related complications (Demeo & Ginns, 2001; 
Studer et al., 2004).  
To allow for early detection and intervention on post-transplant complications, 
LTRs are expected to actively engage in self-management behaviors (De Geest et al., 2005; 
DeVito Dabbs et al., 2009; Dew et al., 2007; Dew, DiMartini, DeVito Dabbs, et al., 2008; 
Finkelstein et al., 1993, 1999). These self-management behaviors include adhering to a 
lifelong medical regimen involving: 1) medication-taking, 2) self-monitoring of both lung 
function and signs and symptoms of complications, and 3) lifestyle recommendations like 
tobacco abstinence. Adhering to these elements of medical regimen has been widely 
recognized to have the potential to maximize the health outcomes among LTRs (De Geest 
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et al., 2005; DeVito Dabbs et al., 2009; Dew et al., 2007; Dew, DiMartini, DeVito Dabbs, 
et al., 2008; Finkelstein et al., 1993, 1999).  
While there is a growing body of literature on adherence behaviors among LTRs, 
translating this body of research to practice requires a systematic examination of the 
evidence. To date, one meta-analysis and two reviews have examined prevalence and risk 
factors of nonadherence among heart transplant recipients, LTRs and heart-lung transplant 
recipients (De Geest et al., 2005; Dew et al., 2007; Korb-Savoldelli et al., 2010). However, 
most of the conclusions from those reviews pertained to heart transplant recipients as very 
few conclusions could be drawn regarding the LTRs population due to a limited number 
of published articles on LTRs at the time of those reviews. For example, in the meta-
analysis by Dew and colleagues (Dew et al., 2007), only 5 articles including LTRs were 
identified for inclusion. This resulted in very few conclusions regarding adherence in this 
population.  
Although LTRs may share some similarities with heart transplant recipients as both 
are cardiothoracic transplant groups, there are unique characteristics and challenges for 
LTRs to adhere to the post-transplant regimen. For example, while both groups are at risk 
for infection due to immunosuppression, LTRs are at particularly high risk for developing 
life-threatening pneumonia infections due to the direct exposure of the pulmonary graft to 
infectious pathogens and post-transplantation physiologic changes in mucous clearance 
(Remund, Best, & Egan, 2012). Thus, in addition to adhering to medication regimen, LTRs 
must adhere to recommendations for daily self-monitoring of pulmonary function. In order 
to maximize their effectiveness in educating and supporting LTRs, nurses and other 
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clinicians must be up to date on the scientific literature on adherence after lung 
transplantation.  
Without a systematic review of the current evidence, it is challenging for clinicians 
to apply research evidence into their care for LTRs. Therefore, our goal was to 
systematically review the evidence regarding the 1) prevalence of nonadherence; 2) risk 
factors for nonadherence; 3) impact of interventions for promoting adherence; and 4) 
outcomes of nonadherence, among LTRs. Our rationale for including articles on outcomes 
of nonadherence was that although there is no doubt that post-transplant medication 
regimen is effective for preventing complications (Taylor, Watson, & Bradley, 2005), less 
is known about the strength of the relationship between nonadherence and outcomes such 
as mortality and morbidity.  
 
2.3 METHODS 
2.3.1 Search strategies 
An electronic literature search was conducted in PubMed MEDLINE, EBSCOhost 
CINAHL, Ovid PsycINFO, Ovid Global Health, and EMBASE. The keywords of “lung 
transplant” or “lung transplantation” were paired with combinations of the terms 
“(non)adherence”, “(non)compliance”, “medication”, “monitoring”, “diet”, “exercise”, 
“alcohol drinking”, “smoking”, “tobacco use”, “substance use” and “spirometry”. 
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Truncation was used to ensure that both noun and verb forms of each word were captured. 
Databases were searched from the earliest available dates through April 1, 2015. 
2.3.2 Inclusion and exclusion criteria 
Articles included in this review met the following criteria: 1) reported LTRs’ post-
transplant nonadherence to any element of the medical regimen, 2) focused on adults (≥ 18 
years old), 3) quantitative research study, and 4) English language. Articles were excluded 
if they met any of the following criteria: 1) did not report post-transplant nonadherence for 
adult LTRs, 2) case study, 3) clinical guideline, 4) conference abstract or proceeding, 5) 
commentary or qualitative study, and 6) review article. 
2.3.3 Data extraction for review 
This project was guided by the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) (Liberati et al., 2009). Each article was screened by at least two 
independent reviewers and if any discrepancies occurred, two reviewers discussed and 
reached an agreement on whether to include the article or not. If no agreement was reached, 
further consultation was sought from the content experts on the team (M.A.D., A.D.D.). 
The screening processes are reported in Figure 1. Key information from each article was 
extracted, including the first author, year, sample size, definitions and measures of 
adherence and findings. We assessed the quality of each article using the level of evidence 
by the Agency for Healthcare Research and Quality (West et al., 2002). A summary of key 
12 
characteristics for each article, organized by the aims of this review, is displayed in Tables 
1, 2, and 3.  
Figure 1 Study Flow Chart
13 
Table 1 Articles on Prevalence and Risk Factors of Nonadherence to Medical Regimen among Lung Transplant Recipients (LTRs) 
First Author 
(Year) 
Country 
Level of 
Evidence 
N Measurement Area of adherence and definition Findings 
Medication Adherence 
Bosma (2011) 
The 
Netherlands 
Level 4 
91 Medication 
Electronic Event 
Monitoring 
(EEM) 
Nonadherence (NA): taking both daily doses of 
tacrolimus at around the recommended time-
points on < 80% days or missing >=1 doses per 
month, following Dew et al. (2008)’s criteria 
Median observation time: 95 days (50-124 days) 
Using 80% criteria, NA rate is 7.7% 
Using Dew’s criteria, NA rate is 15.4% 
Sig. predictors: younger age and lower self-care 
ability 
Dew (2008) 
United States 
Level 3 
178 Health Habits 
Assessment 
(LTRs and 
caregivers 
version) 
NA: missed  >= once a month 
Report from either LTRs or caregivers as 
evidence of NA 
NA rates are 9.6%, 8.3%, 14.3%, 14.5%, and 19.7% 
for baseline-2 months, 2-7 months, 7-12 months, 12-
18 months, and 18-24 months respectively.  
Sig. predictors: relying on public health insurance; 
poor CG and friends’ support.  
De Bleser 
(2011) 
Belgium 
Level 3 
104 1. Self-report
2. Collateral
report
3. Blood Assay
of
Immunosuppress
ant (IS)
4. EEM
5. Composite
adherence (AD)
score (CAS)
1. BAASIS: NA on any items
2. VAS: 0 (NA)-100 (perfect adherence (AD))
3. Collateral report: either physician or nurse
rated patients (pts) as less than ‘good’ is NA
4. Assay: Sub-therapeutic values as NA
5. EEM: (i) taking AD (% of blister removals)
(ii) dosing AD (% days with correct doses),
(iii) timing AD (% days with correct dosing
intervals), (iv) drug holidays (no blister
removals > 24 hours)
6. CAS-1: either (self-report or collateral
report) showed NA; CAS-2: either (self-report
or collateral report or assay) showed NA
NA at baseline (NA at 3-months) 
1. BAASIS – Overall 40.4% (35.9%); Taking NA:
12.6% (10.8%), Timing NA: 36.5% (27.9%)
2. VAS- Median 95 (95)
3. Collateral-Physician: 31.4% (33.3%)
4. Collateral-Nurse: 32.7% (39.3%)
5. Assay: 30.4% (32.1%)
6. CAS-1: 63.1% (63.3%); CAS-2: 71.8% (72.2%)
8. EEM: 13% taking NA; 22.6% timing NA 14.8%
dosing NA; 1.39 % drug holidays
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First Author 
(Year) 
Country 
Level of 
Evidence 
N Measurement Area of adherence and definition Findings 
De Geest 
(2014) 
Switzerland  
Level 3 
181 BAASIS NA: any missing dose  6-months: 2.3% (taking NA); 0 (drug holidays);  
12-months: 9.6% (taking NA); 1.3% (drug 
holidays);  
24-months: 13% (taking NA); 2.3% (drug holidays);  
36-months: 7.3% (taking NA); 0 (drug holidays) 
Goetzmann 
(2009)  
Switzerland 
Level 4 
76 TxEQ-D No definition for NA because they reported 
adherence subscale score as a continuous 
variable  
Observation time: mean 48 months (3-133 months) 
Sig predictors: poor organ integration (meaning 
perceived closeness of transplanted organ to self) 
Hugon (2014) 
France  
Level 3 
33 Morisky-Green 
scale and plasma 
level of IS 
NA: self-reported adherence score was ≤ 4 
and/or had a ratio of inadequate trough 
concentrations (# of assays with less than 
targeted concentrations divided by total # of 
assays) > 0.2 
Observation time: 6 months 
NA rate: 48.5% 
Kugler (2007)  
Germany 
Level 4 
287 subscale of 
investigator -
developed scale 
NA: self-report of a at least one drug holiday 
within the past 14 days 
Observation time: over past 14 days 
NA rate to IS and corticosteroids: 4.5% 
Sig predictors: adverse effects  
Kung (2012)  
New Zealand 
Level 3 
 
46 Immunosuppress
ant therapy 
adherence scale 
(ITAS) 
NA (ITAS score < 12) Observation time: 3 months 
NA rate: 56%;  
Sig. predictors: younger age, completed 
postsecondary education, less convinced that IS 
would prevent organ rejection, and had higher 
symptom distress 
Matthees 
(2001)  
United States 
Level 4 
99 4-item scale  High AD: score of 4;  
Moderate AD: score of 3;  
Low AD: < = 2 
Observation time: median 49.9 months (9-123 
months) 
63% high, 28% moderate, 9% low AD;  
 
O’Brien (2008) 
Australia  
Level 4 
33 Investigator-
developed scale 
Missed one dose since transplant Observation time: mean 51.5 months (0.8-142 
months) 
NA: 48.5%  
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First Author 
(Year) 
Country 
Level of 
Evidence 
N Measurement Area of adherence and definition Findings 
Santana (2009) 
Canada 
Level 4 
43 Morisky scale Ever forgot to take medication over past 6-
months 
Observation time: 6 months 
NA: 9% 
Su (2013) 
Canada 
Level 3 
65  Pharmacy 
dispensing 
record 
NA: medication possession ratio (MPR, days of 
medication supplied/actual days) < 80% 
Observation time: 2 years 
NA rate: 8% 
Teichman 
(2000)  
United States 
Level 4 
31 self-report 
demographic 
questionnaire 
and compliance 
questionnaire by 
subjects, CG, 
and Tx 
coordinator 
Forgot once monthly Observation time: mean 24 months (3-57 months) 
NA rate: 19.5%  
Adherence to Self-Monitoring of Lung Function  
Dew (2008) 
United States 
Level 3 
178 collateral report 
from patients 
and caregivers 
using Health 
Habits 
Assessment 
Performed spirometry less than several times a 
week 
 
Report from either LTR or caregivers as 
evidence of NA 
NA rates are 24.2%, 47.1%, 54.6%, 64.5%, and 
65.9% for baseline-2mons, 2-7mos, 7-12mos, 12-
18mos, and 18-24mos respectively.  
Sig. predictors: relying on public health insurance; 
poor CG and friends’ support; lower internal locus 
of control; female gender 
Kugler (2010)  
Germany 
Level 4 
269 
 
Electronic 
monitoring 
(EM); Hannover 
Treatment 
Adherence 
Questionnaire 
Self-monitoring of lung function (SMLF) 
adherence: one measurement/day  
Adherent: >=90 measurements for the last three 
months 
Observation time: EM: 3 months; self-report: over 
past 14 days 
59.4% NA based on EM vs. 42.6% NA based on 
self-report 
Sig. factors: age, higher education, not member in 
patient organization, belief that SMLF difficult to 
manage, had SMLF deviation, developed 
bronchiolitis obliterans syndrome (BOS), history of 
infections, and had support from Tx center 
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First Author 
(Year) 
Country 
Level of 
Evidence 
N Measurement Area of adherence and definition Findings 
Lindgren 
(2002) 
United States 
Level 4 
139 EM # of days with measurement divided by the 
total adjusted possible days.  
Poor adherence: weekly adherence <70% 
Observation time: 6 months 
18% were poor adherers  
 
Morlion (2002)  
Belgium 
Level 4 
22 EM # of days with measurement sessions divided 
by the total adjusted possible days. 
Observation time: median 473 days (60-822 days) 
NA rate: 16%  
Teichman 
(2000)  
United States 
Level 4 
31 self-report 
demographic 
questionnaire 
and compliance 
questionnaire by 
subjects, CG, 
and Tx 
coordinator 
One measurement per day Observation time: mean 24 months (3-57 months) 
NA rate: 16.7% 
Sig factors: CF patients; patients received Tx more 
recently 
 
Adherence to Other Aspects of Medical Regimen 
Bauldoff (2015) 
United States 
Level 4 
34 Serum cotinine 
and self-report  
Self-report smoking behaviors after the Tx and 
confirmatory findings of serum cotinine 
Observation time: 223-3160 days 
NA rate: 14.7% 
DeVito Dabbs 
(2003) 
United States 
Level 4 
249 Bronchi-alveolar 
lavage 
specimens 
Smoking behaviors based on evidence of 
kaolinate accumulation in macrophages 
Observation time: 1 year 
NA rate: 45% 
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First Author 
(Year) 
Country 
Level of 
Evidence 
N Measurement Area of adherence and definition Findings 
Dew (2008)  
United States 
Level 3 
178  patients and 
caregivers 
collateral report 
of Health Habits 
Assessment 
survey  
Clinic appointments (missed >=1 visit);  
Blood work (missed>=1 appointment);  
Blood pressure monitoring (less than several 
times a week);  
Exercise (less than several times a week);  
Diet (went off diet at least weekly);  
Used tobacco (any use);  
Excessive alcohol use (>=2 drink/day);  
 
They took report from either patient or CG, as 
evidence of NA.  
NA rates are for baseline-2mons, 2-7mos, 7-12mos, 
12-18mos, and 18-24mos respectively.  
tobacco use: 0.0% 0.6% 1.3% 0.7% 1.6% 
alcohol use: 3.9% 4.1% 9.1% 10.9% 10.2% 
clinic appt: 11.8% 22.0% 22.2% 33.3% 27.8% 
blood work: 15.3% 24.3% 24.8% 25.4% 28.3% 
exercise: 31.5% 29.4% 38.3% 35.8% 41.3% 
diet: 28.1% 33.3% 31.2% 30.4% 36.5% 
BP monitor: 42.1% 55.9% 59.2% 67.4% 68.5% 
 
Sig. factors in all domains: relying on public health 
insurance; poor CG and friends’ support.  
Lower internal locus of control and female gender 
predicted increased risks to NA to home self-care 
(BP monitoring, diet or exercise).  
Evon (2005) 
United States 
Level 3 
45 Patient and Tx 
coordinator 
report 
Adherence to Tobacco use: No use at all 
Adherence to Alcohol use: < 2 drinks/day 
Observation time: 1-7 years 
NA to tobacco: 0; NA to alcohol: <40% 
Sig. factors: lower levels of social support. 
McDonald 
(1998) 
United States 
Level 4 
29 Serum cotinine 
and self-report 
NA to tobacco: self-report smoking after Tx 
and confirmatory serum cotinine 
Observation time: 4 years 
NA rate: 13.8% 
Ruttens (2014) 
Belgium 
Level 4 
331  Smoking  
-questionnaire 
-cotinine   
-eCO 
cotinine (>75 ng/ml as positive), eCO (>= 
10ppm as positive) 
Observation time: 1 year 
Overall NA rate: 12% 
Sig. factors: underlying disease, shorter abstinence 
period before Tx, prevalence of solid organ cancer, 
lung cancer 
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First Author 
(Year) 
Country 
Level of 
Evidence 
N Measurement Area of adherence and definition Findings 
Teichman 
(2000)  
United States 
Level 4 
31 self-report 
demographic 
questionnaire 
and compliance 
questionnaire by 
subjects, CG, 
and Tx 
coordinator 
No definition Observation time: mean 24 months (3-57 months) 
Fevers: Sig factors: number of months since Tx; 
social support; health locus of control related to 
powerful others;  
Time in the Sun: A) Strength of sunscreen: Sig. 
factors: younger age; social support;  
Vos (2010) 
Belgium 
Level 4 
267 Smoking  
-questionnaire 
-cotinine   
-eCO 
cotinine (>75 ng/ml as positive), eCO (>= 
10ppm as positive) 
Observation time: median 3.4 years (1.5-6.0 years) 
Overall: 15.7% smoked after Tx 
Sig factors: having the diagnosis of emphysema, 
years of Tx, SES, abstinence period, post-Tx second 
hand tobacco exposure 
AD: adherence; NA: Nonadherence; BAASIS: Basel Assessment of Adherence with Immunosuppressant Medication Scales; VAS: visual analog 
scale; Sig.: significant; TxEQ-D: Transplant Effects Questionnaire; pt: patient; Tx: transplant; BP: blood pressure; CG: caregiver; CF: cystic fibrosis; 
eCO: exhaled carbon monoxide; SES: socioeconomic status  
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Table 2 Articles on Interventions to Promote Adherence among Lung Transplant Recipients (LTRs) 
First Author (year) 
Country 
Study Design 
Level of Evidence 
N Description of Intervention Target area of regimen and definition Findings 
Chlan (1998) 
United States 
Pre-post test 
Level 3 
 43 HS system and research nurse 
tracked pts’ progress and contacted 
pts when needed 
HS measured by electronic spirometer 
Adherent: >= one record/week 
Pre-test: 83.3% (n=29);  
Post-test: 88.5% (n=14) 
(effect size (ES) =.37) 
DeVito Dabbs (2009) 
United States  
Pilot RCT 
Level 1 
30 Smartphone assists LTR to track 
their self-monitoring data with 
decision support to report to 
worrisome values to clinical team 
10 areas measured by Health Habit 
Assessment by caregivers and LTRs 
Overall adherent: adherent to >= 9 areas 
Self-monitoring adherent: > 80% 
HS adherent: ≥ 3 times/week 
Intervention group had a sig. 
higher rate of adherence to daily 
monitoring and performing HS 
than control group (ESs 
are .46, .45, respectively). I 
group also has a higher rate of 
overall adherent (ES=.47). 
Sengpiel (2010) 
Germany 
Pilot RCT 
Level 1 
56 Using Bluetooth, HS data will be 
automatically sent to a database, 
which can generate alarm messages 
HS measured by electronic spirometer 
Good adherence: ≥ 80%;  
Moderate adherence: 50%-79%;  
NA: <50% 
Intervention group had an 
adherent rate of 97.2% while the 
control group had 95.2% 
(ES=.05).  
Goldstein (1996) 
United States  
Quasi-experiment 
Level 2 
23 Clinic: rushed education about HS, 
self-monitoring  
PLC: tailored education 
HS measured by electronic spirometer 
No definition  
# of records 
Clinic 3mos(6mos): 46.8 (84.1) 
PLC 3mos(6mos): 62.4 (108.2) 
ES=.28 
LaVelle (2010) 
United States  
Correlational  
Level 3 
48 All pts received a HS system, 
education about HS, a quarterly 
educational newsletter 
HS measured by electronic spirometer 
Adherent: > 1 blow a week, adjusted for 
special occasions.  
Increased perceived 
worthwhileness of the newsletter 
was correlated with higher 
percentage of weeks the subjects 
were adherent to HS (ES=.36). 
Suhling (2014) 
Germany 
RCT 
Level 1 
64 iPad-based education vs. paper-
based education on medication 
adherence 
Medication adherence: 
- physician rating: good, moderate, bad
adherence
- surveys: BAASIS, VAS, Morisky (no
definition was provided)
No difference in physician 
rating or surveys assessments of 
adherence between two groups 
(ES=.11).  
HS: home spirometry; pts: patients; PLC: problem-based learning center; BAASIS: Basel Assessment of Adherence with Immunosuppressant 
Medication Scales; VAS: visual analog scale; ES: effect size; I: Intervention; C: Control; NA: nonadherence; sig.: significant;  
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Table 3 Articles on Clinical Outcomes of Nonadherence among Lung Transplant Recipients 
BOS: bronchiolitis obliterans syndrome 
First Author (year) 
Country 
Level of Evidence 
N Area of regimen and 
definition  
Outcome 
measures 
Findings 
Yoon (2008) 
United States 
Level 4 
246 Home spirometry 
Adherent: ≥ once/week 
High adherence: > 75% 
Low adherence: ≤ 75% 
Survival time 
Mortality 
High adherence group had better survival but not significant 
(effect size, ES=.08) 
Cumulative incidence of pulmonary-related death is reduced 
with better adherence to home spirometry, but not significant 
(ES=.09) 
Cumulative incidence of non-pulmonary death was similar for 
two groups (ES=.02) 
Kugler (2009) 
Germany 
Level 4 
226  Home spirometry 
Adherent: ≥ once/day 
Good adherer: ≥ 80% 
Moderate adherer: 50%-79%  
Nonadherer: < 50%  
Graft loss  
Incidence of BOS 
Re-transplantation 
No significant impact of adherence on patient survival 
(ES=.03) 
Significant shorter time free from BOS in nonadherers 
compared with good or moderate adherers (ES=.16) 
Tendency toward lower re-transplantation rates for good 
adherers (ES=.12)  
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2.3.4 Data Analysis 
To address the fact that LTR participants had different follow-up duration across studies, 
we calculated the person-time incidence nonadherence rates. Specifically, we calculated 
the number of cases of nonadherence per 100 person-years for each study in each element 
of medical regimen. The effect sizes of intervention impact on promoting adherence and 
relationships between nonadherence and clinical outcomes were examined by extracting or 
calculating correlation coefficients.  
2.4 RESULTS 
As shown in Figure 1, 30 articles were included in this review: 22 (73.3%) focused on 
prevalence and/or risk factors of nonadherence (see Table 1), 6 (20.0%) articles examined 
the effects of interventions to promote adherence (see Table 2), and 2 (6.7%) articles 
explored outcomes related to nonadherence (see Table 3). The sample sizes ranged from 22 
to 331 with a pooled total sample size of 3,388. The samples were predominantly 
comprised of individuals who were white, middle aged, married or living with partners, 
and carried a diagnosis of obstructive disease or cystic fibrosis. These sample 
characteristics are consistent with the characteristics of the worldwide LTRs population 
(Yusen et al., 2014). 
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2.4.1 Prevalence and Risk Factors of Nonadherence to the Medical Regimen 
Nonadherence to medication-taking 
Medication nonadherence was examined in thirteen articles (Bosma et al., 2011; 
De Bleser et al., 2011; Sabina De Geest et al., 2014; Dew, DiMartini, DeVito Dabbs, et al., 
2008; Goetzmann et al., 2009; Hugon et al., 2014; Kugler et al., 2007; Kung, Koschwanez, 
Painter, Honeyman, & Broadbent, 2012; Matthees et al., 2001; O’Brien, Aslani, Ciccia, & 
Brien, 2008; Santana et al., 2009; Su et al., 2013; Teichman et al., 2000), with rates ranging 
from 2.3% to 72.2%. When taking different follow-up time in consideration, the 
medication nonadherence rates ranged from 4 to 100 cases for every 100 persons in a given 
observation year. Approaches to defining and measuring medication nonadherence varied 
within this set of articles. Some articles (De Bleser et al., 2011; Dew, DiMartini, De Vito 
Dabbs, et al., 2008; Kugler et al., 2007) defined medication nonadherence as any missing 
dose over a month or between study follow-ups, while others defined medication 
nonadherence as following the medication instructions less than 80% of the days over 3 
months (Bosma et al., 2011; Su et al., 2013). Across articles, self-report approaches (with 
or without collateral report) to measure medication nonadherence were the most common, 
with fewer articles incorporating measures like electronic medication event monitoring 
(Bosma et al., 2011; De Bleser et al., 2011) or records of pharmacy dispensing (Su et al., 
2013). One article used a combined approach of self-report and plasma concentration of 
immunosuppressant (Hugon et al., 2014). Notably, among the articles using self-report 
measures, a variety of the scales were used with most of scales being validated in other 
chronic diseases or other solid transplant recipients, and their reliability and validity among 
LTRs was generally unreported (De Bleser et al., 2011; Sabina De Geest et al., 2014; 
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Hugon et al., 2014; Kugler et al., 2007; O’Brien et al., 2008; Santana et al., 2009; Teichman 
et al., 2000).  
Among those 13 articles on medication nonadherence, 6 reported associated risk 
factors among LTR participants (Bosma et al., 2011; Dew, DiMartini, DeVito Dabbs, et 
al., 2008; Goetzmann et al., 2009; Kugler et al., 2007; Kung et al., 2012; Matthees et al., 
2001). None of the factors were examined in a sufficient number of articles (i.e., >5) to 
allow for a meta-analysis. Of the factors that were examined in more than one article, our 
synthesis revealed conflicting results. For example, one article (Kung et al., 2012) found 
that higher educational level was a significant predictor of nonadherence to medication 
while two other articles (Bosma et al., 2011; Dew, DiMartini, DeVito Dabbs, et al., 2008) 
reported that level of education was not significantly related to medication nonadherence.  
 
Nonadherence to self-monitoring of lung function   
Five articles examined nonadherence to self-monitoring of lung function with rates 
ranging from 16% to 65.9% (Dew, DiMartini, DeVito Dabbs, et al., 2008; Kugler, Gottlieb, 
et al., 2010; Lindgren et al., 2002; Morlion et al., 2002; Teichman et al., 2000). When the 
follow-up duration was considered, the calculated rates ranged from 8.3 to 100 cases per 
100 person-years. No standard definition was found across articles. For example, one 
article (Kugler, Gottlieb, et al., 2010) defined adherence to self-monitoring of lung function 
as performing home spirometry once daily while another article (Lindgren et al., 2002) 
classified poor adherers as weekly adherence of less than 70%. Three articles used 
electronic monitoring (Kugler, Gottlieb, et al., 2010; Lindgren et al., 2002; Morlion et al., 
2002) while the other two articles (Dew, DiMartini, et al., 2008; Teichman et al., 2000) 
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used a combination of sources, including collateral reports from family caregivers or 
transplant coordinators to validate patients’ self-reports. Similar to the results of 
nonadherence to medication-taking, no conclusive risk factors for nonadherence to 
performing spirometry were identified due to limited evidence and/or inconsistent findings 
across the articles.  
 
Nonadherence to other aspects of the post-transplant medical regimen 
Nonadherence to other aspects of the post-transplant medical regimen was also 
examined in several articles, including tobacco use, alcohol use, and having blood work 
performed as prescribed. Seven articles (Bauldoff, Holloman, Carter, Pope-Harman, & 
Nunley, 2015; DeVito Dabbs et al., 2003; Dew, DiMartini, DeVito Dabbs, et al., 2008; 
Evon et al., 2005; McDonald, Keller, Ramos, & Brunt, 1998; Ruttens et al., 2014; Vos et 
al., 2010) examined nonadherence to tobacco use. While two articles (Dew, DiMartini, et 
al., 2008; Evon et al., 2005) found low nonadherence rates (less than 2%), other articles 
(Bauldoff et al., 2015; DeVito Dabbs et al., 2003; McDonald et al., 1998; Ruttens et al., 
2014; Vos et al., 2010) reported higher nonadherence rates, ranging from 12% (Ruttens et 
al., 2014) to 45% (DeVito Dabbs et al., 2003). When translating these rates to the person-
time incidence rate, nonadherence to tobacco ranged from 0 to 52.3 cases/100 person-years. 
Each of these articles treated any tobacco use after the transplantation as nonadherent. Two 
articles (Dew, DiMartini, et al., 2008; Evon et al., 2005) used patients’ reports and 
collateral reports from family caregivers, and/or transplant coordinators, while the others 
used a combination of self-report and/or a physiologic measure like urine test of cotinine 
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(McDonald et al., 1998; Ruttens et al., 2014; Vos et al., 2010) serum cotinine (Bauldoff et 
al., 2015) or biopsy data (DeVito Dabbs et al., 2003).  
2.4.2 Interventions for Promoting Adherence 
Six articles reported on the effects of interventions to promote adherence (Chlan et al., 
1998; DeVito Dabbs et al., 2009; Goldstein et al., 1996; Lavelle et al., 2010; Sengpiel et 
al., 2010; Suhling et al., 2014), four of which focused on adherence to performing home 
spirometry (Chlan et al., 1998; Goldstein et al., 1996; Lavelle et al., 2010; Sengpiel et al., 
2010), one on adherence to medication-taking (Suhling et al., 2014) and one on adherence 
to the overall medical regimen (DeVito Dabbs et al., 2009). All of these studies had a 
relatively small sample size, ranging from 23 to 64. Many of them failed to describe the 
theoretical basis for the design of the interventions (Chlan et al., 1998; Goldstein, Snyder, 
Edin, Lindgren, & Finkelstein, 1996; Lavelle et al., 2010; Sengpiel et al., 2010; Suhling et 
al., 2014). In addition, the interventions focused exclusively on patient level factors despite 
increasing awareness that adherence is a multidimensional issue including patient, 
condition, treatment and health system factors (De Geest et al., 2005; Dew et al., 2007; 
Dew, DiMartini, DeVito Dabbs, et al., 2008; World Health Organization, 2003). Lastly, 
these studies followed participants for limited periods, typically 2 months. This relatively 
brief period of follow-up precludes determining patterns of adherence over an extended 
period when adherence is likely to decline. 
The interventions designed to promote adherence to home spirometry shared 
common features (Chlan et al., 1998; DeVito Dabbs et al., 2009; Goldstein et al., 1996; 
Lavelle et al., 2010; Sengpiel et al., 2010). First, all of these interventions included an 
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educational component. Participants were instructed regarding the purpose, importance of, 
and skills needed to perform home spirometry. Second, they all used some form of 
technology to assist participants to better track their lung function at home. Third, the 
spirometry data were usually date-stamped, transmitted to the study center, and reviewed 
by the study team. Fourth, all of the studies provided some automatic decision support 
feedback; sent either to participants to report changes to their care team (DeVito Dabbs et 
al., 2009; Sengpiel et al., 2010) or sent directly to a member of the care team, typically the 
transplant coordinator (Chlan et al., 1998; Goldstein et al., 1996; Lavelle et al., 2010). With 
regard to the effects of interventions on promoting adherence, the calculated effect sizes 
using correlation coefficients ranged from 0.05 (Sengpiel et al., 2010) to 0.45 (DeVito 
Dabbs et al., 2009).  
Two articles examined interventions to promote adherence to medication-taking 
(DeVito Dabbs et al., 2009; Suhling et al., 2014). Both studies were randomized controlled 
trials and used mobile technology as an interventional tool. In one study (Suhling et al., 
2014), a nurse interventionist used an iPad at the time of hospital discharge to provide a 
single educational session about medication adherence, while the other study (DeVito 
Dabbs et al., 2009) provided smartphones to participants for 2 months. Compared to the 
conventional paper-based education, the one-time iPad-based patient education at 
discharge did not show a significant improvement in adherence to medication-taking 
(effect size r=0.11) (Suhling et al., 2014); however, LTRs who were randomized to the 
smartphone intervention reported a significantly higher overall adherence (including 10 
elements of post-transplant medical regimen, one of which is medication adherence) 
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compared to patients in the usual care group (effect size r=0.47) (DeVito Dabbs et al., 
2009).  
2.4.3 Outcomes of Nonadherence 
Two articles examined clinical outcomes of nonadherence to home spirometry among 
LTRs (Kugler et al., 2009; Yoon et al., 2008). One study (Kugler et al., 2009) used a 
prospective design while the other (Yoon et al., 2008) used a retrospective design. Both 
articles used electronic spirometers, which stored measurements in the device and 
transmitted the data to the study center. These articles adopted different criteria to define 
adherence. Yoon and colleagues (2008) considered once per week as adherent. However, 
Kugler et al. (2009) defined adherence as once per day and classified participants into 3 
groups: good adherers (>=80%), moderate adherers (50%-79%), and nonadherers (<50%). 
Both found weak correlations (0.03-0.08) between adherence and patient survival. In 
addition, Kugler et al. (2009) reported correlations between nonadherence and other 
clinical outcomes such as time free from bronchiolitis obliterans syndrome (BOS), a form 
of the chronic graft rejection, and re-transplantation rates (correlation coefficients: 0.12-
0.16).  
2.4.4 Strength of the Evidence 
According to the Agency for Healthcare Research and Quality (West et al., 2002), strength 
of evidence for articles included in this review can be categorized as the following (see 
Table 1, 2, and 3 for details): the majority (n=17, 56.7%) were level 4 (descriptive articles 
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without any control group); nine were level 3 (observational articles with controls), 
including either other solid organ transplant recipients or lung transplant candidates as 
comparison groups; one was level 2 (non-randomized controlled trials) and three were level 
1 (randomized controlled trials). 
2.5 DISCUSSION 
To the best of our knowledge, this is the most recent systematic review of evidence 
regarding nonadherence to the medical regimen among LTRs. We included 30 articles, 22 
of which focused on prevalence and/or risk factors of nonadherence, a number greatly 
increased since the last review in this area, which found only 5 articles focusing on 
prevalence and/or risk factors of nonadherence among LTRs (vs. 72 for kidney and 34 for 
heart recipients) (Dew et al., 2007). This increase in the volume of published articles 
indicates that progress has been made over the last few years in the field of adherence 
among LTRs. Yet, compared to the study of kidney or heart transplantation, the body of 
available evidence is still relatively small.  
In the current review, nonadherence rates to different elements of the medical 
regimen for LTRs varied greatly and could not be consistently attributed to any specific 
factor, which is consistent with findings for other solid organ transplant recipients (De 
Geest et al., 2005; Dew et al., 2007). This may be due to the methodological heterogeneity 
of each study (i.e., different study design, sample size, settings, measures, and rigor) 
(Gagnier, Moher, Boon, Beyene, & Bombardier, 2012) or could be attributed to the 
  29 
complexity of nonadherence behaviors (WHO, 2003). More exploratory studies are needed 
in LTRs population to better inform the content and targets of interventions going forward.  
It is acknowledged that in the field of transplantation there is a push for more 
interventional studies to promote medical regimen adherence (Cupples et al., 2006). 
Examination of effect sizes across the 6 intervention studies included in this review showed 
that the impact of interventions on promoting adherence to performing home spirometry 
ranged from 0.05 (Sengpiel et al., 2010) to 0.45 (DeVito Dabbs et al., 2009). The variations 
in the effect sizes might be explained by the methodological issues mentioned in the results 
section, including relatively small sample sizes, lack of theoretical basis for intervention, 
an exclusive focus on patient-level factors and limited follow-up times (i.e., 2 months). 
These issues are consistent with problems identified in another review of interventions 
studies on promoting medication adherence (De Bleser, Matteson, Dobbels, Russell, & De 
Geest, 2009). More large-scale studies are needed to test theory-driven and evidence-based 
interventions in LTRs for an extended follow-up time.  
Our review found that better adherence to home spriometry was significantly 
associated with prolonged time free from BOS and a tendency toward lower need for re-
transplantation (Kugler et al., 2009; Yoon et al., 2008). Yet, neither study found a 
significant impact of nonadherence on patient survival. Studies in other solid organ 
transplant recipients have also failed to demonstrate such significance (De Geest et al., 
1995; Denhaerynck et al., 2009). This suggests that other mechanisms may also contribute 
to patient survival and need to be further explored to promote transplant health outcomes.   
A pervasive issue impacting this body of literature is the varying definitions of 
nonadherence. For example, one study defined adherence to home spirometry as one 
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measurement per day (Kugler et al., 2009) while another study defined it as one 
measurement per week (Yoon et al., 2008). The variations in the definitions may be driven 
by the varying recommendations provided at each transplant center, which presents a 
challenge to the process of aggregating findings across the studies. In addition, there was 
a notable variation in the self-report measures employed and limited discussion of the 
reliability and validity of the measures among LTRs. These weaknesses underscore the 
importance of clearly defining and striving for consistency in measuring nonadherence 
through combined approaches.  
An emerging trend of using technology-based interventions to promote adherence 
was observed in this review, especially in those interventional studies where mobile 
technology or home telemonitoring system was used to assist participants to adhere to self-
monitoring with or without decision-support (Chlan et al., 1998; DeVito Dabbs et al., 2009; 
Goldstein et al., 1996; Lavelle et al., 2010; Sengpiel et al., 2010; Suhling et al., 2014). The 
use of technologies to measure nonadherence (i.e., electronic medication monitoring) 
(Bosma et al., 2011; De Bleser et al., 2011) was also noted in this review. These trends are 
likely reflective of the rapidly growing roles of information technology in the field of health 
care (Free et al., 2013). Future studies could further explore how to maximize the use of 
technologies to better measure and promote adherence among LTRs (DeVito Dabbs, Song, 
Myers, et al., 2013).   
While this review pointed out several problems in the adherence literature among 
LTRs population, we also noted several encouraging indicators of progress in the field. 
First, our review found that several recent studies acknowledged nonadherence as a 
complex and multidimensional problem (WHO, 2003) and explored system-related risk 
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factors (Dew et al., 2008; Kugler et al, 2010). For example, Dew et al. (2008) reported that 
relying exclusively on public health insurance was a significant risk factor for 
nonadherence to all domains of medical regimen among 178 LTRs, which provided an 
important implication for healthcare policy and pointed to the need of involving 
multidisciplinary stakeholders to address this challenging issue. This is a remarkable 
paradigm shift as compared to previous studies mostly focused on patient-related factors 
(i.e., patients’ beliefs and attitudes). Second, a growing number of studies have started to 
use multiple strategies and combined approaches to measure adherence, which aligns well 
with the current recommendations of adherence literature (Dew et al., 2007; Dew, 
DiMartini, et al., 2008; DiMatteo, 2004). Lastly, while the conclusive evidence on risk 
factors is lacking in LTRs population, researchers are still actively designing and 
conducting pilot interventions studies based on clinical observation and evidence from 
other fields (i.e., non-transplant chronic disease). Some pilot work has even demonstrated 
promising results in promoting adherence among LTRs (DeVito Dabbs et al., 2009).  
There are several limitations to acknowledge for this review. First, qualitative 
research, grey literature such as conference abstracts, and literature in other than English 
language were not reviewed, which might limit our knowledge in this area. Second, studies 
regarding pediatric LTRs were excluded, which limited the generalizability of our findings. 
Lastly, as is true in other reviews, our findings might be biased due to the fact that 
researchers are more likely to publish studies with positive results (Easterbrook, Berlin, 
Gopalan, & Matthews, 1991; Olson, 2008).    
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2.6 CONCLUSIONS 
This review provides an overview of the evidence in nonadherence to the post-transplant 
medical regimen among adult LTRs over the past 20 years. While encouraging progress 
has been made, we identified several implications and knowledge gaps in the field. 
Future research should consider: (1) applying more rigorous and standard methodologies 
to define and measure adherence, while accounting for clinical variations in patient 
instructions; (2) conducting more large-scale randomized trials to test theory-driven and 
evidence-based interventions; and (3) exploring ways to better utilize the currently 
available information technology to promote medical regimen adherence and ultimately 
achieve better health outcomes among LTRs. 
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3.0  MANUSCRIPT 2: PATTERNS AND CORRELATES OF SELF-CARE AGENCY 
IN LUNG TRANSPLANT RECIPIENTS OVER THE FIRST 12-MONTHS POST-
HOSPITAL DISCHARGE AFTER TRANSPLANT 
INTRODUCTION TO MANUSCRIPT 2 
This chapter includes manuscript 2, which addresses the second specific aim of the dissertation 
study: Aim 2: Identify distinct patterns and correlates of self-care agency (SCA) among LTRs 
over the first 12-months post-hospital discharge after transplant. 
One of the limitations identified in the systematic review (manuscript 1) is that there is a 
general lack of theoretical basis for adherence research among LTRs. This chapter focuses on a 
critical theoretical construct in self-care theory (Orem, 2001), self-care agency, which is defined 
as one’s willingness and ability to perform self-care behaviors. While a prior report found that the 
majority of LTRs perceived high SCA prior to discharge (DeVito Dabbs et al., 2013), it is unclear 
whether and how SCA changes over time after transplantation. Understanding the longitudinal 
patterns and correlates of this potentially important theoretical concept may help inform the design 
of future self-care promotion interventions among LTRs. In this study, we took advantage of an 
existing dataset, employed an advanced statistical technique, group-based trajectory modeling, and 
identified distinct patterns of SCA among LTRs over the first 12-months post-discharge from 
transplant hospitalization. Based on the identified patterns, we examined both baseline and 
longitudinal correlates of SCA patterns.  
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3.1 ABSTRACT 
Background: Actively engaging in post-transplant self-care may help to maximize health 
outcomes for lung transplant recipients (LTRs). Self-care agency (SCA), defined as one’s ability 
and willingness to perform self-care, has been identified as a key factor influencing one’s 
performance of self-care behaviors. Understanding patterns and correlates of SCA over time may 
inform the design of self-care promotion interventions in LTRs. Therefore, we sought to identify 
patterns and correlates of SCA among LTRs over the first 12-months post-hospital discharge after 
transplant. 
Methods: This correlational secondary analysis used data from the usual care group (N=102) of a 
completed randomized controlled trial. Group-based trajectory modeling was used to identify 
distinct patterns of SCA (as measured by Perception of Self-Care Agency) over the first 12-months 
post-hospital discharge after transplant. Baseline (meaning prior to discharge) measures of 
sociodemographic, clinical, and psychosocial factors, as well as longitudinally assessed 
psychological distress were examined for their associations with predicted trajectory group 
membership using ordinal logistical regression and linear mixed modeling, respectively. 
Results: Three distinct stable (zero-slope) SCA trajectories were identified: persistently low, 
persistently moderate, and persistently high. Based on the final parsimonious multivariate model, 
having been re-intubated during the transplant hospitalization (p=.043), discharged to a facility 
rather than home (p=.048), and endorsing a higher baseline anxiety level (p=.001) were 
significantly associated with membership in the persistently low SCA group. Linear mixed models 
revealed that higher anxiety and depression levels were associated with lower SCA in the 
persistently moderate and low SCA groups over 12-months (ps<.05).  
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Conclusions: Given the negative relationship between psychological distress and SCA, future 
interventions to promote SCA should consider assessing and reducing psychological distress 
among LTRs. 
3.2 INTRODUCTION 
Over the last few decades, lung transplantation has been increasingly performed for individuals 
with end-stage lung diseases (Yusen et al., 2014) and has led to markedly improved quality of life 
(Kugler et al., 2005; Rodrigue, Baz, Kanasky, & MacNaughton, 2005; Vasiliadis, Collet, & 
Poirier, 2006). As a medically complex and chronically ill population, lung transplant recipients 
(LTRs) are prescribed a lifelong medical regimen to follow after the transplantation. LTRs are 
expected to perform a variety of self-care behaviors such as adhering to medication taking, self-
monitoring of their lung functions, vital signs and symptoms, and communicating critical changes 
to their transplant coordinators in a timely manner (De Geest, Dobbels, Fluri, Paris, & Troosters, 
2005; DeVito Dabbs et al., 2009; Dew et al., 2007, 2008). Despite the widely agreed importance 
of these self-care behaviors, accumulating evidence shows that LTRs’ actual performance of these 
behaviors is suboptimal and far below the recommended levels (DeVito Dabbs et al., 2003; Dew 
et al., 2007; Hugon et al., 2014; Kugler, Gottlieb, et al., 2010; Kung et al., 2012).  
Orem’s theory of self-care (Orem, 2001) purports that self-care agency (SCA), defined as 
one’s ability and willingness to engage in self-care behaviors, influences how well an individual 
performs a wide variety of self-care behaviors across many chronic illness populations (Baker & 
Denyes, 2008; Bosma et al., 2011; Callaghan, 2003, 2006; Dale et al., 2012; Drevenhorn et al., 
2015; Hu et al., 2014; Ovayolu et al., 2012; Wang et al., 2014; Wong et al., 2015). Furthermore, 
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the self-care theory posits that SCA is influenced by sociodemographic, clinical, and psychosocial 
characteristics of an individual (Callaghan, 2006; Orem, 2001; Sousa, Hartman, Miller, & Carroll, 
2009).  
Although SCA has gained much attention in individuals with chronic conditions such as 
diabetes, hypertension, and arthritis, research regarding SCA after lung transplantation is limited. 
To date, only one study has described levels of SCA and examined its correlates among LTRs 
prior to discharge from their transplant surgery (DeVito Dabbs et al., 2013). DeVito Dabbs and 
colleagues (2013) found that LTRs reported higher levels of SCA than patients with other chronic 
diseases and suggested one possible explanation was that prior to discharge when SCA was 
assessed, LTRs might be overly confident about their capability to perform self-care behaviors at 
home. Thus, DeVito Dabbs and colleagues (2013) called for future work to explore the 
longitudinal patterns of SCA among LTRs.  
Given the key role that self-care behaviors play in promoting health outcomes after lung 
transplantation, it is important to more fully understand the longitudinal patterns and correlates of 
SCA to guide the development of interventions to promote SCA or prevent a decline in SCA 
among LTRs. Therefore, the purposes of this study were to: 1) explore the distinct patterns of SCA 
and 2) examine correlates of SCA among LTRs over the first 12-months post-hospital discharge 
after transplant.  
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3.3 METHODS 
3.3.1 Study design 
This study was a correlational secondary analysis of data collected during a randomized controlled 
trial (NR107011, PI: DeVito Dabbs) (DeVito Dabbs, Song, Myers, et al., 2013). The aims of the 
parent study were to examine the efficacy of the Pocket PATH®, a mobile health intervention, 
compared to usual care for promoting self-care behaviors (primary outcomes), self-care agency 
and transplant-related health (secondary outcomes) among LTRs over the first 12-months post-
hospital discharge after transplant (DeVito Dabbs, Song, Myers, et al., 2013). 
3.3.2 Sample and setting 
Eligibility for this study was identical to that of the parent study. Inclusion criteria included LTR 
who should be: 1) > 18 years of age; 2) stable enough to be transferred from the cardiothoracic 
ICU to the acute care unit; and 3) able to speak and read English; LTRs who: 1) had received any 
prior transplant or 2) were unable to perform their self-care were excluded. All LTRs were 
recruited from the Cardiothoracic Transplant Program of the University of Pittsburgh Medical 
Center. 
 The sample for this study was comprised of the 102 LTRs who were randomized to the 
usual care arm. The rationale to focus only on this usual care group is to avoid the possible 
intervention effect on SCA. The sample used for this secondary analysis partially overlapped with 
the sample reported in DeVito Dabbs et al. (2013), which focused on baseline data (prior to 
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randomization) for 111 LTRs, whereas this longitudinal investigation included all LTRs in the 
usual care arm.  
3.3.3 Procedures 
We obtained IRB approval for both parent study and the current study. As part of the usual care, 
all LTRs were prepared to perform self-care behaviors during a one-on-one education session with 
a transplant coordinator who provided written materials and a spirometer for LTRs to monitor lung 
function at home (DeVito Dabbs, Song, Myers, et al., 2013). LTRs were instructed to self-monitor 
changes in health parameters such as temperature, spirometry readings, and symptoms for possible 
complications and to record these data on paper and pencil logs (DeVito Dabbs, Song, Myers, et 
al., 2013). Prior to hospital discharge, all potential eligible LTRs were approached and asked to 
sign written informed consent to participate in the parent RCT. Baseline data were collected by 
trained interviewers after the standard discharge education but prior to discharge and the 
randomization. All participants were re-assessed at 2, 6, and 12-months post-hospital discharge 
after transplant.   
3.3.4 Measures 
Dependent Variable - Self-care agency (SCA): We used the 53-item, self-report instrument, 
Perception of Self-Care Agency (Hanson & Bickel, 1985), to measure LTRs’ perceptions of their 
level of SCA. The survey uses a 5-point Likert scale with higher scores indicating higher perceived 
SCA (possible score range, 53 to 265). A sample item is “I can choose what is important and least 
important when taking care of myself” with the responses ranging from never like me (1) to always 
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like me (5). The reliability of this scale based on Cronbach’s alpha has been established in prior 
studies (Gast et al., 1989; Hanson & Bickel, 1985; DeVito Dabbs et al., 2013). Cronbach’s alpha 
was 0.94 in this current sample. This scale was completed at baseline (meaning post-transplant but 
immediately prior to discharge) and at 2, 6, and 12-months post-hospital discharge after transplant. 
 
Potential Correlates of SCA: The following potential correlates were selected to be consistent 
with the factors outlined by Orem’s self-care theory (2001) and prior research in LTRs and other 
chronic illness populations (Akyol et al., 2007; Bağ & Mollaoğlu, 2010; Callaghan, 2003; 
Callaghan, 2006; Dale et al., 2012; DeVito Dabbs et al., 2013; Fex et al., 2012; Karagozoglu et al., 
2012; Lauck et al., 2009; Yildirim et al., 2013)  
Socio-demographic Correlates: Characteristics, such as age, gender, race, employment 
status, marital status, education, and whether respondents felt that their income met their needs 
were collected at baseline using a Socio-demographic Profile. Given the small number of non-
white participants, race was excluded as an analysis variable in the model building processes. 
Clinical Correlates: Data for factors including type of lung transplant (single vs. double), 
underlying lung disease (obstructive vs. non-obstructive), and need for re-intubation (yes vs. no), 
duration of ventilation (< 48 hours vs. ≥ 48 hours), number of days in ICU, number of days with 
chest drain, length of hospital stay (days), and discharge destination (home vs. other facilities) 
during the transplant hospitalization were abstracted from the medical record. 
Psychosocial Correlates 
Quality of recipient-caregiver relationship: The quality of the relationship between 
LTRs and their caregivers was assessed at baseline using a 15-item, self-report questionnaire 
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adapted from the Dyadic Adjustment Scale (DAS) (Spanier, 1976); higher scores indicate higher 
relationship quality (Cronbach’s alpha = 0.80 in the present sample).  
Health locus of control: The Multi-Dimensional Health Locus of Control Scale (B. S. 
Wallston & Wallston, 1978; K. A. Wallston, Wallston, & DeVellis, 1978) was used to measure 
LTRs’ beliefs about responsibility for control over health outcomes at baseline. LTRs rated the 
extent to which they believed their health outcomes were: 1) their own responsibility (Internality) 
2) due to chance (Chance subscale) or 3) their health care professionals’ responsibilities 
(Externality subscale) (Cronbach’s alpha in the present sample was 0.78, 0.77 and 0.43, 
respectively). Higher subscale scores indicate stronger control beliefs. We omitted externality 
subscale from our analysis because the Cronbach’s alpha for this subscale was low. 
Psychological distress: The Anxiety and Depression subscales of the Symptom Checklist 
90-Revised (SCL-90-R) (Derogatis, 1994) was used to measure psychological distress at all four 
time points, baseline, 2-, 6-, 12-months post-hospital discharge after transplant. The subscales 
focus on the past two weeks and use a 5-point rating scale (0=not at all to 4=extremely distressed). 
Higher scores indicate higher levels of distress. The subscale scores were obtained by averaging 
item scores. Cronbach’s alpha in the current sample was 0.86 for the anxiety and 0.82 for 
depression subscale. 
 
3.3.5 Statistical analysis 
Descriptive analyses were performed using IBM® SPSS® Statistics for Windows (version 23, IBM, 
Corp., Armonk, NY). The significance level was set to .05 for two-tailed hypothesis testing. For 
continuous variables without outliers, we reported means and standard deviations. For continuous 
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variables with outliers, we reported medians and inter-quartile ranges. Categorical variables were 
summarized using frequency counts and percentages.  Outliers for each variable were examined 
and replaced with the next highest/lowest values that are not outliers (Hastings, Mosteller, Tukey, 
& Winsor, 1947). We did not impute any missing data given that the missingness was found to be 
missing completely at random (MCAR) (SPSS MCAR test p=.53), which can be handled directly 
by the trajectory modeling (Jones, Nagin, & Roeder, 2001; Jones & Nagin, 2007; Nagin, 2005). 
The TRAJ procedure (PROC TRAJ) in SAS (version 9.4, SAS Institute, Cary, NC) was 
used to perform group-based trajectory modeling (Jones et al., 2001; Jones & Nagin, 2007; Nagin, 
2005) to identify distinct trajectories of SCA over the first 12 months post-hospital discharge after 
transplant. Censored normal model was chosen because the dependent variable, SCA, is a 
continuous variable. We determined the appropriate number of groups and the shapes of 
trajectories by comparing Bayesian Information Criteria (BIC) and Bayes factor for competing 
models (Jones et al., 2001; Jones & Nagin, 2007; Nagin, 2005).  
 We applied ordinal logistic regression (using PLUM routine in SPSS) to examine the 
baseline correlates of predicted membership by the trajectory modeling. In order to maximize the 
ratio of sample size to number of variables, we first performed univariate ordinal logistic 
regression considering each variable singly to screen for candidate variables for the multivariate 
modeling. Only those with p-values equal or less than 0.30 from the univariate modeling were 
considered as candidate variables for the multivariate modeling (Babyak, 2004; Steyerberg, 
Eijkemans, Harrell, & Habbema, 2001). Given the relatively small sample size for this 
investigation, we used a liberal 0.30 p-value cutoff for univariate screening in order to retain likely 
important variables in the final model (Babyak, 2004; Steyerberg et al., 2001). Using a backward 
elimination approach, a final parsimonious multivariate model was determined where all retained 
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variables were statistically significant (p<0.05).  The proportional odds assumption was tested and 
met for all ordinal logistical regressions. For the longitudinally measured psychosocial correlates 
(anxiety and depression), we applied linear mixed modeling to examine the associations between 
these time-dependent covariates (dependent variable, DV) and the predicted group membership 
for SCA (independent variable, IV) over the first 12-months post-hospital discharge after 
transplant.  
3.4 RESULTS 
Sample Characteristics  
We excluded 8 participants who died during the study, leading to a final sample of 94 LTRs. There 
was no difference between these 8 participants and the rest of the sample, except that those 8 LTRs 
were more likely to be discharged to facilities other than home. Table 4 summarizes the 
sociodemographic, clinical and psychosocial characteristics of the sample. These characteristics 
were representative of the lung transplant population in the United States (Organ Procurement and 
Transplantation Network, 2012).  
Table 4 Sample Characteristics at Baseline (N=94) 
Baseline Characteristics Mean±SD or n(%) 
Sociodemographics 
Age (Years) 57.20 (13.58) 
Male 56 (59.6%) 
White 83 (88.3%) 
> High School 63 (67.0%) 
Not currently working 86 (91.5%) 
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Income met needs 75 (79.6%) 
Currently married 67 (71.3%) 
Clinical Correlates 
Obstructive lung disease 40 (42.6%) 
Re-intubated post-transplant (No) 67 (71.3%) 
Bilateral lung transplant 78 (83.0%) 
< 2 days on ventilator 59 (62.8%) 
Discharge to home 81 (86.2%) 
Length of ICU stay (days)* 7 (11.25) 
Chest drain (days)* 12 (10.00) 
Length of hospital stay (days)* 33 (28.00) 
Psychosocial Correlates 
DAS-Quality of recipient-
caregiver relationship*  
(possible score range: 0-75) 
67.00 (7.75) 
MHLC-Internal subscale 
(possible score range: 6-36) 
 
23.71 (6.59) 
MHLC-Chance subscale 
(possible score range: 6-36) 
18.26 (7.10) 
SCL-90 Anxiety* 
(possible score range: 0-4) 
0.40 (0.65) 
SCL-90 Depression* 
(possible score range: 0-4) 
0.50 (0.51) 
Note: *Median and interquartile range was used to describe those variables given there are outliers 
for those variables.  
SD: Standard Deviation; DAS: Dyadic Adjustment Scale; MHLC: Multidimensional Health Locus 
of Control; SCL: Symptom Checklist  
 
 
 
44 
Trajectories of Self-Care Agency 
Based on the group-based trajectory modeling, a model with three distinct stable (i.e., zero 
slope) trajectory groups provided best fit to the data (BIC=-1573.58). As shown in Figure 2, group 
1 (persistently low SCA) consisting of 21.34% of the sample (n=20) was characterized by a flat 
trajectory (zero slope) with an intercept of 199.65 (p<.001). This group had a relatively low SCA 
(199.65 out of 265) at baseline that persisted throughout the 12 months of follow-up. Group 2 
(persistently moderate SCA, n=46, 48.64%), also had a flat trajectory (zero slope) but with a 
relatively higher intercept (intercept, b0=223.32, p<.001). This trajectory was characterized by a 
moderate level of SCA (223.32 out of 265) at baseline that persisted at this level over 12 months 
of follow-up. Group 3 (persistently high SCA, n=28, 30.01%) with a flat zero-slope trajectory 
(b0=247.26, p<.001). These participants started at a relatively high level of SCA (247.26 out of 
265) compared to the other two groups and stayed at this level over 12 months of follow-up.
*Note: Solid lines are based on actual SCA scores and dashed lines are based on predicted values from
group-based trajectory modeling.
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Figure 2 Trajectory Groups for Self-Care Agency (SCA) over the First 12-months after Discharge 
from Lung Transplant*  
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Baseline Correlates of Membership in the Persistently Low SCA Group 
As reported in Table 5, 7 candidate correlates met the threshold of p<.30 based on the 
univariate analyses and were included in the full multivariate model for membership in the 
persistently low SCA group: age, need for re-intubation, discharge destination, length of stay, pre-
discharge anxiety, pre-discharge depression, and quality of recipient-caregiver relationship. Using 
a backward elimination approach, we obtained the most parsimonious model with only 3 correlates 
retained, including requiring a re-intubation during hospital stay (OR=2.61, 95% CI: 1.03-6.55, 
p=.043), discharged to a facility other than home (OR=3.53, 95% CI: 1.01-12.30, p=.048), and 
higher baseline level of anxiety (OR=4.06, 95% CI: 1.79-9.21, p=.001).  
Table 5 Baseline Correlates of Membership in the Persistently Low Self-Care Agency (SCA) Group  
Baseline Correlates 
Univariate Model for 7 
Candidate Correlates
Parsimonious Multivariate 
Model after Backward 
Elimination at p (removal) ≥.05 
OR 95% CI p OR 95% CI p 
Age (years)* 1.02 0.99, 1.05 .15 
Discharged to any facility 
other than home 
4.76 1.49, 14.29 .01 3.53 1.01, 12.30 .048 
Re-intubated during hospital 
stay 
2.56 1.08, 6.25 .03 2.61 1.03, 6.55 .043 
Length of hospital stay (days)* 1.02 1.00, 1.04 .07 
Quality of caregiver-recipient 
relationship 
0.92 0.86, 0.97 .004 
SCL-90 Anxiety 4.35 1.92, 9.09 <.001 4.06 1.79, 9.21 .001 
SCL-90 Depression* 4.17 1.92, 1.85 .001 
Notes: *These correlates were dropped in the final parsimonious model when using backward 
elimination approach.  
b: regression coefficient; OR: Odds Ratio; CI: Confidence Interval; p: p-value; SCL: Symptom Checklist 
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Longitudinal Correlates of SCA  
Table 6 shows the descriptive statistics (means and standard deviations) and the linear 
mixed modeling results for longitudinal correlates of SCA. There was a significant group effect 
(p=0.002) for anxiety, suggesting that the changes in anxiety score over the 12 months were 
distinctly different among the three SCA groups such that the persistently high SCA group had 
significantly lower anxiety levels than both the persistently low SCA group (p=0.03) and the 
persistently moderate SCA group (p=0.049) (Figure 3). There was a significant group effect 
(p<0.001) and group by time interaction effect (p=0.01) for depression, suggesting that the changes 
in depression among the three SCA groups differed over time (Figure 4). Specifically, significantly 
lower levels of depression were observed in the persistently high SCA group relative to those 
observed in both the persistently low SCA group (p=0.002) and the persistently moderate SCA 
group (p<0.001). This suggests that higher depression levels were associated with relatively lower 
SCA levels in persistently moderate and low SCA groups. These overall patterns of differing 
depression levels across the three groups held up even though there were within group changes in 
depression levels at varying time points (Figure 4).  Specifically, depression levels decreased at 
the 6-month interval within the moderate SCA group and increased within the low SCA group but 
neither of these changes were of a magnitude large enough to match the depression levels observed 
within the other groups.    
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Table 6 Descriptive Statistics (mean and standard deviation) and Linear Mixed Modeling Results for 
Longitudinally Assessed Correlates by Predicted Self-Care Agency (SCA) Trajectory Groups  
Persistently 
Low SCA 
Persistently 
Moderate SCA 
Persistently 
High SCA 
p-values
Group Time 
Group by 
Time 
Interaction 
SCL-90 
Anxiety 
.002 .08 .16     2 months 0.80 (0.61) 0.55 (0.50) 0.22 (0.26) 
    6 months 0.72 (0.54) 0.44 (0.39) 0.33 (0.42) 
   12 months 0.48 (0.38) 0.41 (0.40) 0.22 (0.28) 
SCL-90 
Depression 
<.001 .09 .01     2 months 1.03 (0.72) 0.66 (0.56) 0.29 (0.27) 
6 months 1.06 (0.61) 0.55 (0.34) 0.44 (0.40) 
    12 months 0.70 (0.44) 0.65 (0.36) 0.27 (0.25) 
SCA: Self-Care Agency; SCL: Symptom Checklist 
Figure 3 Levels of Anxiety over 12-months by Three Self-Care Agency (SCA) 
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Figure 4 Levels of Depression over 12-months by Three Self-Care Agency (SCA) 
Trajectory Groups 
3.5 DISCUSSION 
This study examined patterns of SCA over the first 12-months post-hospital discharge after 
transplant. Three patterns of SCA were identified: a persistently low SCA group, a persistently 
moderate SCA group and a persistently high SCA group. This suggests that SCA levels remained 
relatively stable within each group over time. Of particular note, there were approximately 20 
points differences in SCA levels among the three trajectory groups. While higher scores indicate 
higher perceived SCA, it is unclear whether these 20 points reflect clinically meaningful 
differences.  
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 While we found that under a usual care condition SCA levels were stable, others have 
demonstrated that SCA is responsive to interventions and can improve over time (DeVito Dabbs 
et al., 2009; Drevenhorn et al., 2015). For example, DeVito Dabbs and colleagues (2009)  
demonstrated that a mobile health intervention significantly increased SCA and overall adherence 
among LTRs compared to the usual care group. These findings suggest the importance of assessing 
LTRs’ SCA prior to discharge and intervening early to reinforce and/or strengthen LTRs’ SCA 
(Cebeci & Çelik, 2007), and ultimately to promote better health outcomes over time.  
This study also examined correlates associated with patterns of SCA. We found that LTRs 
who required re-intubation during the transplant hospitalization or were discharged to care 
facilities other than home, were more likely to report a lower level of SCA. Requiring a re-
intubation or discharged to care facilities may indicate the poor physical health status of LTRs. 
The relationship between poorer physical health and lower SCA has been reported in other chronic 
diseases population (Lukkarinen & Hentinen, 1997; Ovayolu et al., 2012). It is possible that poor 
physical health status diminishes one’s confidence in ability to perform self-care behaviors (Sabati, 
Snyder, Edin-Stibbe, et al., 2001). In cases where SCA is likely to be significantly compromised 
by poor health over time, it may be important to engage family caregivers as co-managers of the 
LTRs’ health post-transplant (DeVito Dabbs, Song, De Geest, & Davidson, 2013; Dew et al., 2008; 
Rosenberger, Dew, DiMartini, DeVito Dabbs, & Yusen, 2012).    
The current study revealed a significant negative correlation between psychological 
distress and SCA level with higher levels of baseline anxiety associated with lower SCA. This 
finding is consistent with the earlier report (DeVito Dabbs et al., 2013) which found that LTRs 
with higher psychological distress level prior to discharge were more likely to report lower SCA. 
This negative relationship has also been reported in other populations, such as patients with chronic 
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obstructive pulmonary diseases (Yildirim et al., 2013), coronary heart disease (Lukkarinen & 
Hentinen, 1997), and patients receiving percutaneous coronary intervention (Lauck et al., 2009). 
The current study confirms that baseline distress levels are inversely related to baseline SCA 
levels, and that this association persists over time. Psychological distress has been shown to 
negatively influence a person’s motivation, self-concept and ability to problem solve and cope 
(Coleman & Newton, 2005). This may explain why LTRs with higher distress report lower SCA, 
highlighting the importance of monitoring psychological distress over time and intervening to 
reduce the distress among LTRs following transplantation when needed. 
Several limitations were noted in this study. As a secondary data analysis, the study is 
limited to the data collected for the parent study, which precludes the possibility of including other 
potential associated factors noted in the literature such as sense of coherence (defined as ability to 
deal with stressors) (Dale et al., 2012; Fex, Flensner, Ek, & Söderhamn, 2012). The sample was 
recruited from a single transplant program, which may limit the generalizability of our research 
findings, although the sample was representative of LTRs population in the United States (Organ 
Procurement and Transplantation Network, 2012). We only focused on the group who were 
randomized to the usual care group, which limited our sample size. However, we employed several 
strategies (i.e., univariate screening and backward elimination) and ensured that the respondent-
to-variable ratio met the suggested target of 10:1 (Tabachnick & Fidell, 2007). Lastly, some of the 
correlates, such as the quality of recipient-caregiver relationship, were only measured at baseline, 
limiting our ability to explore how these correlates may be associated with SCA over time. 
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3.6 CONCLUSIONS 
In conclusion, this is the first study to examine longitudinal patterns of SCA and its associated 
correlates over the first 12-months after discharge from transplant hospitalization. Three stable 
patterns of SCA were identified, indicating that under usual care conditions, over the first 12-
months post-hospital discharge after transplant, SCA is a relatively stable phenomenon. The 
negative association between psychological distress and SCA points to important targets for 
strengthening SCA, promoting self-care, and ultimately optimizing health outcomes after lung 
transplantation. 
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4.0  MANUSCRIPT 3: PATTERNS AND CORRELATES OF ADHERENCE TO 
SELF-MONITORING IN LUNG TRANSPLANT RECIPIENTS DURING THE FIRST 
12-MONTHS AFTER DISCHARGE FROM TRANSPLANT 
INTRODUCTION TO MANUSCRIPT 3 
This chapter reports findings regarding the third aim of this dissertation, that is, Aim 3: Identify 
distinct patterns and correlates of adherence to self-monitoring in LTRs over the first 12-months 
post-hospital discharge after transplant.  
 Among the elements of post-transplant medical regimen, we specifically focused on 
adherence to self-monitoring among LTRs because adherence to this element is particularly 
difficult for LTRs (DeVito Dabbs et al., 2009; Dew, DiMartini, et al., 2008) and the cumulative 
incidence rate for nonadherence to self-monitoring was unacceptably high (i.e., more than 62.0% 
nonadherence rate by the end of 2 year post-transplant) (Dew, DiMartini, et al., 2008). Despite the 
prevalence of this issue, limited evidence is available regarding the longitudinal patterns and 
correlates of adherence to self-monitoring among LTRs. Therefore, to address this gap, we 
examined longitudinal patterns and correlates of adherence to self-monitoring among LTRs during 
the first 12-months post-discharge from transplant hospitalization.  
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4.1 ABSTRACT 
Background: Lung transplant recipients (LTRs) often experience complications such as graft 
rejection and infection. Daily self-monitoring of lung function, vital signs and symptoms is crucial 
to ensure early detection of complications and prompt intervention. Yet, nonadherence to self-
monitoring among LTRs is high and little is known regarding the patterns and correlates of 
adherence to self-monitoring among LTRs. This study sought to explore patterns and correlates of 
adherence to self-monitoring among LTRs over the first year post-discharge from transplant. 
Methods: This correlational secondary analysis used data from participants assigned to the usual 
care arm of a randomized clinical trial who tracked self-monitoring activities using paper-and-
pencil logs. Adherence was calculated as the percent of days LTRs recorded any self-monitoring 
data per interval: hospital discharge to ≤2 months, > 2 to ≤6 months, and >6 to ≤12 months. Group-
based trajectory modeling was used to identify trajectory patterns of adherence to self-monitoring. 
Binary logistic regression and linear mixed modeling were used to examine baseline and 
longitudinal correlates of predicted group membership. 
Results: The sample (N=91) was mostly white (87.9%), male (61.5%), with a mean age of 57.19 
(SD=13.76) years. Group-based trajectory analyses revealed 2 groups: 1) moderately adherent 
with slow decline (n=29, 31.9%) and 2) persistently nonadherent (n=62, 68.1%). Multivariate 
binary logistic regression revealed the following baseline correlates of membership in the 
persistently nonadherent group: female (p=.035), higher baseline anxiety (p=.008), and weaker 
sense of personal control over health (p=.005). Poorer physical health over 12-months were 
associated with the membership in the persistently nonadherent group (p<.05). 
Conclusions: This study revealed two adherence patterns and highlighted several modifiable 
factors for the membership in the persistently nonadherent to self-monitoring group, suggesting 
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future interventions should aim to reduce post-transplant anxiety, and strengthen sense of control 
for one’s own health in LTRs.   
4.2 INTRODUCTION 
To date, more than 47,000 persons have undergone lung transplantation worldwide, a number 
largely limited by the scarcity of organ donors (International Society for Heart and Lung 
Transplant, 2015). Despite improved physical functioning and quality of life, lung transplant 
recipients’ survival is often compromised by the high susceptibility to infections and graft rejection 
(Demeo & Ginns, 2001; DeVito Dabbs et al., 2003; Trulock et al., 2007; Yusen et al., 2014) with 
approximately 75% of LTRs developing infection and 50% developing acute rejection during the 
first year post-transplantation (Burguete, Maselli, Fernandez, & Levine, 2013). Thus, there is a 
pressing need to detect complications early and intervene promptly to maximize outcomes in 
LTRs. Frequent self-monitoring of health conditions at home has been shown as a reliable and 
valid approach for early detection and prompt treatment-seeking to reduce morbidity and mortality 
(Finkelstein et al., 1993; Morlion et al., 2002; Otulana et al., 1990).  
Prior to discharge, LTRs are instructed to perform self-monitoring activities including daily 
assessment of lung function using a home spirometer, vital signs, and common symptoms of post-
transplant complications (Chhajed, Tamm, Malouf, & Glanville, 2002; Chlan et al., 1998; 
Finkelstein et al., 1996, 1999; Goldstein, Snyder, Edin, Lindgren, & Finkelstein, 1996; Kugler et 
al., 2009, 2010; Kukafka, O’Brien, Furukawa, & Criner, 1997; Yoon et al., 2008). One study 
showed that 100% adherence to home self-monitoring reduced total post-transplant medical costs 
by more than 50% (Adam, Finkelstein, Parente, & Hertz, 2007). Despite the well-recognized 
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importance of self-monitoring, adherence to self-monitoring among LTRs is less than ideal (Dew, 
DiMartini, DeVito Dabbs, et al., 2008; Kugler et al., 2009, 2010; Lindgren et al., 2002; Morlion, 
Knoop, Paiva, & Estenne, 2002; Teichman, Burker, Weiner, & Egan, 2000; Yoon et al., 2008) 
with nonadherence rates for performing spirometry reportedly as high as 54.6% and 65.9% at 12 
and 24 months post-transplant, respectively (Dew, DiMartini, et al., 2008). Without a clear 
understanding of the patterns and correlates of adherence to self-monitoring, it is difficult to design, 
implement, and evaluate interventions to address this problem.  
According to the World Health Organization (WHO) (World Health Organization, 2003), 
there are five major dimensions affecting adherence behaviors: 1) social/economic factors; 2) 
patient-related factors; 3) condition-related factors; 4) therapy-related factors; and 5) health 
system-related factors. Factors in each of the five dimensions have been examined in the context 
of adherence to self-monitoring after lung transplantation (Dew, DiMartini, DeVito Dabbs, et al., 
2008; Kugler, Gottlieb, et al., 2010; Lindgren et al., 2002; Teichman et al., 2000). Yet, the 
published evidence regarding the correlates of adherence to self-monitoring has been limited in 
several ways. First, the evidence to date is limited in quantity. Our recent literature search of five 
large medical and nursing databases yielded only four published studies that examined the 
correlates of adherence to self-monitoring among LTRs (Dew, DiMartini, DeVito Dabbs, et al., 
2008; Kugler, Gottlieb, et al., 2010; Lindgren et al., 2002; Teichman et al., 2000). Second, results 
from these four studies were inconsistent, limiting the conclusions that can be drawn about the 
correlates of adherence to self-monitoring. For example, age was not a significant correlate of 
adherence to self-monitoring of lung function in Dew et al. (2008) and Teichman et al. (2000), 
while Kugler and colleagues (2010) found that younger age (<40 years old) was significantly 
correlated with poorer adherence to home spirometry. Third, several methodological issues limit 
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the strength of the evidence, including small sample sizes (Teichman et al., 2000), reliance on 
cross-sectional study designs (Kugler, Gottlieb, et al., 2010; Lindgren et al., 2002; Teichman et 
al., 2000), and varying definitions of adherence to self-monitoring of lung function (Dew, 
DiMartini, et al., 2008; Kugler, Gottlieb, et al., 2010; Lindgren et al., 2002; Teichman et al., 2000). 
Finally, little is known about patterns of adherence to self-monitoring over time. To address this 
gap and identify distinct groups of individuals who demonstrate similar adherence patterns over 
time, in this study we used group-based trajectory modeling (Jones et al., 2001; Jones & Nagin, 
2007). The aims of this study were to: 1) describe distinct patterns of adherence to self-monitoring 
and 2) identify correlates (representing each dimension of the WHO model) associated with 
patterns of adherence to self-monitoring during the first year after discharge from transplantation. 
4.3 METHODS 
4.3.1 Study design 
This study was a correlational secondary analysis of data from a completed randomized controlled 
trial, Phase III Trial of Pocket PATH: A Computerized Intervention to Promote Self-Care 
(NR107011, PI: DeVito Dabbs) (DeVito Dabbs, Song, Myers, et al., 2013). The primary aim of 
the parent study was to test the efficacy of the Pocket PATH®, a mobile health intervention, 
relative to usual care to promote self-care behaviors (including adherence to daily self-monitoring) 
during the first year following discharge from the transplant hospitalization (DeVito Dabbs, Song, 
Myers, et al., 2013). 
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4.3.2 Sample and setting 
We examined only the usual care group of the parent study for this investigation. This decision 
was made for the reason that our aim was to describe underlying patterns of adherence to self-
monitoring but the Pocket PATH intervention might influence adherence to self-monitoring. 
Eligibility criteria for this current study were: 1) lung transplant recipient; 2) > 18 years of age; 3) 
be stable enough to be transferred from the cardiothoracic intensive care unit (ICU) to the acute 
care unit; 4) be able to speak and read English, 5) no previous organ transplantation, 6) expected 
to be involved in post-transplant care, and 7) randomized to the control condition (usual care). All 
participants were recruited from the Cardiothoracic Transplant Program of the University of 
Pittsburgh Medical Center prior to hospital discharge. IRB approval was obtained for the parent 
and current study. 
4.3.3 Measures 
Outcome Variable: Adherence to Self-Monitoring. Prior to discharge, participants in the usual 
care group were instructed to daily self-monitor a variety of health indicators on paper logs, 
including lung function using home spirometry, vital signs and symptoms. Adherence was 
calculated as the percent of days LTRs recorded data for any health indicator on the paper logs and 
this was calculated for each of the three intervals (hospital discharge to ≤2 months, > 2 to ≤6 
months, and >6 to ≤12 months). These intervals were informed by the time intervals used in 
previous research (Dew, DiMartini, et al., 2008) and were also selected to be consistent with the 
measurement time points in the parent study (DeVito Dabbs, Song, Myers, et al., 2013) and to 
reflect typical intervals for follow up visits in clinical care. Total days per interval were adjusted 
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for any days that LTRs were re-hospitalized and therefore not expected to perform self-monitoring. 
The decision to count monitoring in any of these areas rather than analyzing the data for each type 
of self-monitoring activity was based on the following reasons. First, there is precedence for this 
approach in the literature, with at least 6 recent publications treating self-monitoring as a global 
concept (Adam et al., 2007; DeVito Dabbs et al., 2009, 2016; Finkelstein et al., 2013; Mullan et 
al., 2003; Wang et al., 2013). Second, from a clinical perspective, the instruction to self-monitor 
is typically delivered as one recommendation to perform self-monitoring behaviors for a related 
set of health indicators (vital signs, spirometer readings, and symptoms). Third, review of the 
descriptive data (i.e., frequency distribution) for each area of self-monitoring in our dataset 
revealed a similar degree of recording for vitals signs and spirometer readings.  
 
Potential Correlates of Adherence to Self-Monitoring. The identification of the 
potential correlates of adherence that were examined in our analyses was informed by prior studies 
(Dew, DiMartini, De Vito Dabbs, et al., 2008; Kugler, Gottlieb, et al., 2010; Lindgren et al., 2002; 
Teichman et al., 2000) and based on the five dimensions of the WHO adherence model: 
social/economic, patient-related, condition-related, therapy-related, and healthcare system factors 
(World Health Organization, 2003). 
Social/Economic factors included socio-demographic characteristics and the quality of 
the patient’s relationship with his/her family caregiver. Socio-demographic characteristics were 
collected at baseline and included age, education, gender, race, employment status, marital status, 
and whether the respondents felt that their income met their household needs. Given that there was 
limited number of non-white or currently employed LTRs or LTRs who felt their income did not 
meet needs in this study, we omitted these variables for model building processes. The quality of 
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the patient’s relationship with his/her family caregiver was measured at baseline using the 15-item 
adapted Dyadic Adjustment Scale (DAS) (Spanier, 1976). Higher scores indicate better 
relationship quality. Cronbach’s alpha was 0.80 for this current sample.  
Patient-related factors included self-care agency and the patient’s health locus of control. 
Self-care agency, defined as ones’ willingness and ability to perform self-care, was assessed using 
a 53-item scale, Perception of Self-Care Agency (Hanson & Bickel, 1985), at baseline, 2-, 6-, and 
12-month post-discharge. Higher scores indicate higher levels of perceived self-care agency. 
Cronbach’s alpha was 0.94 for our present sample. The 18-item Multi-Dimensional Health Locus 
of Control Scale (B. S. Wallston & Wallston, 1978; K. A. Wallston et al., 1978) (MHLC) was 
administered at baseline to measure the extent to which LTRs believed that health outcomes were 
1) their own responsibility (internality) (Cronbach’s alpha = 0.78 for this current sample), 2) their 
health professionals’ responsibility (externality) (Cronbach’s alpha = 0.43 for this current sample), 
or 3) determined by chance alone (chance) (Cronbach’s alpha = 0.77 for this current sample). 
Higher scores reflect stronger beliefs in each of the three domains. Given that Cronbach’s alpha 
was relatively low (0.43) for the externality subscale, we dropped it from our analysis.  
Condition-related factors included the underlying lung disease, levels of anxiety and 
depression, and physical and mental health-related quality of life. The underlying lung disease 
(obstructive vs. non-obstructive) was collected from the medical record. The anxiety and 
depression subscales of the Symptom Checklist-90 (SCL-90) (Derogatis & Unger, 2009; Rodin & 
Voshart, 1986) were administered at baseline, 2-, 6-, and 12-month post-hospital discharge to 
assess symptoms of psychological distress during the past two weeks. Items were formatted using 
a 5-point Likert scale (0 “not at all” to 4 “extremely distressed”). The subscale scores were 
calculated by averaging the score for each item (Derogatis & Unger, 2009; Rodin & Voshart, 
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1986). Higher scores indicate greater levels of psychological distress (anxiety or depression). 
Cronbach’s alpha was 0.86 and 0.82 for anxiety and depression subscales, respectively, in our 
current sample. The physical component and mental component summary scores, calculated based 
on the 8 subscales of the Medical Outcomes Study Short Form-36 (MOS SF-36) (Ware & Gandek, 
1998; Ware & Sherbourne, 1992),  were used to assess LTRs’ health-related quality of life at 2-, 
6-, and 12-month post-discharge. In this current sample, the Cronbach’s alpha for the 8 subscales 
ranged from 0.79 to 0.96. Higher scores reflect better health-related quality of life.  
Therapy-related factors included the type of transplant, whether re-intubated or not post-
transplant, days requiring chest tubes, and whether post-operation ventilator needs exceeded 48 
hours. Data for each of these variables were abstracted from medical record review at baseline.  
Health system-related factors included length of hospital stay, number of days in ICU, 
and discharge destination. We abstracted these data from medical record review.  
4.3.4 Statistical analysis 
Descriptive analyses were conducted using IBM® SPSS® Statistics (Version 23, IBM Corp., 
Armonk, NY). The level of statistical significance was set at 0.05 for two-tailed hypothesis testing. 
Data were screened for data anomalies (e.g., nonnormality, outliers, multicollinearity) and the 
amount and patterns of missing data. We calculated means and standard deviations for continuous 
variables without outliers and frequencies and percentages for categorical variables. For 
continuous variables with outliers, we reported median and interquartile ranges. We replaced 
outliers for each variable with the next highest/lowest values that are not outliers (Hastings et al., 
1947).  
We used PROC TRAJ in SAS (Version 9.4, SAS Institute Inc., Cary, NC) to perform the 
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group-based trajectory modeling (Jones et al., 2001; Jones & Nagin, 2007; Nagin, 2005) to identify 
distinct patterns of adherence to self-monitoring in LTRs during the first 12 months after discharge 
from transplant hospitalization. Based on Bayesian Information Criteria (BIC) values for 
competing models, the model with smallest BIC based on Bayes factor was chosen as having the 
best fit. Given that our data were found to be missing completely at random (MCAR) (SPSS 
MCAR test p=.96) and trajectory modeling is able to handle this type of missingness, imputation 
for missing data was not applied.  
For baseline correlates, we applied univariate logistic regression analyses to examine the 
association between each correlate and the predicted group membership. Baseline correlates with 
p-values less than 0.30 in the univariate models were considered as candidates for the multivariate 
logistic regression models. We chose this liberal p-value cutoff as this approach is more likely to 
retain important factors in the final model given a small sample size (Babyak, 2004; Steyerberg et 
al., 2001). A backward elimination approach using likelihood ratio Chi-squared test statistic 
(Babyak, 2004; Steyerberg et al., 2001) was used to identify the final most multivariate 
parsimonious model retaining candidate factors significant at p<0.05. We calculated crude and 
adjusted odds ratios (ORs) with 95% confidence intervals (CIs).  
For longitudinal correlates, we conducted linear mixed modeling to examine their 
associations with predicted group membership. These longitudinal correlates included self-care 
agency, SF-36 physical component summary (PCS), SF-36 mental component summary (MCS), 
and SCL-90 Anxiety and Depression subscales. We reported group effect, time effect and group 
by time interaction effect for each longitudinal correlate.  
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4.4 RESULTS 
Sample. Individuals who did not provide any adherence data (n=3) and those who died during the 
study (n=8) were excluded from the analysis, which yielded a final sample of 91 LTRs for analysis. 
The excluded individuals were more likely to be female, have a diagnosis of obstructive lung 
disease, and report poorer quality of relationship with their caregivers.  
Baseline characteristics of the total sample are displayed in Table 7. The total sample was 
predominantly white (87.9%), male (61.5%), and currently married (70.3%), with a mean age of 
57.19 (SD=13.76) years. Most participants had above a high school education (68.1%) and 
reported having incomes that met their needs (80.0%). 
Table 7 Sample Characteristics and Baseline Correlates of Membership in the Persistently 
Nonadherent to Self-Monitoring Group Based on Univariate Logistic Regression Analyses 
Correlates 
Total Sample 
 (N=91) 
 M±SD 
 or n (%) 
Adherence to Self-Monitoring 
Moderately 
adherent 
with slow 
decline 
group 
(n=29) 
M±SD 
or n (%) 
Persistently 
nonadheren
t group 
(n=62) 
M±SD 
or n (%) 
Unadjuste
d Odd 
Ratio 
95% CI 
Social/Economic 
Age (years) 57.19±13.76 58.62±15.47 56.52±12.97 0.99 0.96, 1.02 
> High school education 62 (68.1%) 20 (69.0%) 42 (67.7%) 0.95 0.37, 2.44 
Currently employed 7 (7.7%) 3 (10.3%) 4 (6.5%) n/a n/a 
Non-white 11 (12.1%) 1 (3.4%) 10 (16.1%) n/a n/a 
Female 35 (38.5%) 6 (20.7%) 29 (46.8%) 3.37 1.21, 9.41 
Income met needs: No 18 (20%) 2 (6.9%) 16 (26.2%) n/a n/a 
Currently married or living with
a partner 64 (70.3%) 23(79.3%) 41 (66.1%) 0.51 0.18, 1.44 
Quality of dyadic relationship* 68.00±7.00 68.00±9.75 67.00±5.50 0.98 0.92, 1.06 
Patient-related 
MHLC internal subscale 23.96±6.48 26.72±6.27 22.66±6.21 0.90 0.83, 0.97 
MHLC chance subscale 18.29±7.02 17.80±6.43 18.52±7.32 1.02 0.95, 1.08 
Self-care agency 222.24±23.90 224.14±20.78 221.35±25.3 1.00 0.98, 1.01 
Condition-related 
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Note: *Medians and inter-quartile ranges were reported for those variables with outliers.  
M: Mean; SD: Standard deviation; CI: Confidence Interval; MHLC: Multidimensional Health Locus of 
Control; ICU: Intensive Care Unit; SCL-90: Symptom Checklist 90. 
 
Patterns of Adherence to Self-Monitoring. Group-based trajectory modeling revealed that there 
were 2 adherence trajectory patterns: 1) moderately adherent with slow decline and 2) persistently 
nonadherent. As shown in Figure 5, the moderately adherent with slow decline group (n=29, 
31.89%) started with 63.84% adherence to self-monitoring and linearly declined at a small slope 
(b1=-4.03, p=0.002) over time. The persistently nonadherent group (n=62, 68.11%) started at a 
low percent of adherence (10.02%) at 2 months and declined to 1% adherence at 6-months and 0% 
at 12 months, meaning they performed minimal self-monitoring over 12 months. This group 
declined at a much greater slope (b1=-12.34, p=0.007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obstructive lung disease  37 (40.7%) 10 (34.5%) 27 (43.5%) 1.47 0.59, 3.66 
SCL-90 anxiety score* 0.40±0.73 0.30±0.30 0.50±0.95 4.26 1.37, 13.28 
SCL-90 depression score 0.62±0.55 0.44±0.34 0.70±0.61   3.15 1.05, 9.42 
Treatment-related      
Single lung transplant  16 (17.6%) 7 (24.1%) 9 (14.5%)   0.53 0.18, 1.61 
Re-intubated  26 (28.6%) 6 (20.7%) 20 (32.3%) 1.83 0.64, 5.19 
Post-op ventilator needs ≥48 
hours 35 (38.5%) 7 (24.1%) 28 (45.2%)   2.59 0.97, 6.94 
Days with chest drain* 12.00±8.75 12.50±10.25 12.00±8.00  1.00 0.95, 1.06 
Healthcare system-related      
Length of hospital stay (days)* 31.00±27.00 27.00±25.00 33.00±28.25 1.01 0.99, 1.03 
Days in ICU* 6.00±10.00 4.00±5.00 7.00±11.50 1.01 0.97, 1.05 
Discharge to any home setting  78 (85.7%) 24 (82.8%) 54 (87.1%) 0.71 0.21, 2.40 
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Figure 5 Estimated Trajectory Groups of Adherence to Self-Monitoring  
 
 
Note: Solid lines are mean percent adherence based on raw data and dashed lines are predicted 
mean percent adherence based on trajectory modeling.  
 
Baseline Correlates of Adherence to Self-Monitoring. As displayed in Table 8 (Model 1), 8 
candidate correlates met the threshold of p<0.30 based on the univariate analyses, including: 
gender, marital status, internal health locus of control, anxiety, depression, type of transplant, 
whether re-intubated post-transplant, and post-operation ventilator needs. Using a backward 
elimination approach, we obtained the most parsimonious model with only 3 correlates retained, 
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including gender, internal health locus of control, and anxiety (See Model 2 in Table 8). More 
specifically, the adjusted odds of being in the persistently nonadherent group (as opposed to the 
moderately adherent with slow decline group) was 3.39 (95% CI, 1.09-10.53) for females, 1.14 
(95% CI: 1.04-1.26) for every one unit decrease in internal health locus of control, and 6.08 (95% 
CI, 1.60-23.07) for every one unit increase in anxiety.  
Table 8 Adjusted Odds Ratios for Membership in the Persistently Nonadherent Group Based on 
Multivariate Logistic Regression 
a Model 1: represents the multivariate model with all possible candidate correlates (p < 0.30) identified 
from univariate logistic regression analyses 
b Model 2: represents the most parsimonious model with all correlates in the model significant at p < 0.05 
after applying backward elimination to Model 1 
OR: Odds Ratio; CI: Confidence Interval; MHLC: Multidimensional Health Locus of Control; SCL-90: 
Symptom Checklist 90.  
Baseline Correlates 
Adjusted OR 
(95% CI) 
in Model 1a 
Adjusted OR 
(95% CI) 
in Model 2b 
Social/Economic 
Female  2.54 
(0.66, 9.76) 
3.39 
(1.09, 10.53) 
Currently married 0.82 
(0.21, 3.28) 
Patient-related 
MHLC Internal subscale score 1.14 
(1.03, 1.25) 
1.14 
(1.04, 1.26) 
Condition-related 
SCL-90 anxiety score  7.41 
(0.95,57.69) 
6.08 
(1.60, 23.07) 
SCL-90 depression score 0.75 
(0.11, 5.12) 
Treatment-related 
Single lung transplant  0.76 
(0.20, 2.91) 
Re-intubated: Yes  1.27 
(0.36, 4.45) 
Post-op ventilator needs >=48 hours 1.80 
(0.52, 6.24) 
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Longitudinal Correlates of Adherence to Self-Monitoring 
Table 9 summarizes the descriptive statistics (means and standard deviations) and the linear 
mixed modeling results for longitudinal correlates of adherence to any self-monitoring including, 
self-care agency, physical component summary score, mental component summary score, anxiety 
and depression subscales. Given that our aim was to examine whether these longitudinal correlates 
were associated with the predicted membership, we mainly focused on identifying group effects 
or group by time interaction effects. There was a significant group effect for the physical 
component summary score (p=0.004), suggesting that lower physical component summary scores 
of the quality of life measure were associated with the membership in the persistently nonadherent 
group over the 12 month of observation. All the other longitudinal correlates were not significant. 
Table 9 Descriptive Statistics (mean and standard deviations) and Linear Mixed Modeling 
Results for Longitudinal Correlates by Predicted Trajectory Group Membership 
Correlates 
Moderately 
adherent with 
slow decline 
group 
(n=29) 
Persistently 
nonadherent 
group 
(n=62) 
p-values
Group Time Group*Time Interaction 
Self-Care Agency 
0.13 0.52 0.05     2 months 227.21 (26.94) 226.03 (22.50)     6 months 235.28 (21.06) 223.25 (23.18) 
    12 months 232.71 (24.17) 225.29 (23.85) 
SF-36 PCS 
0.004 <0.001 0.47     2 months 41.58 (7.85) 36.99 (9.30)     6 months 45.59 (9.33) 38.91 (10.93) 
    12 months 46.11 (8.80) 41.52 (10.51) 
SF-36 MCS 
0.58 0.13 0.56     2 months 51.65 (11.99) 51.44 (10.78)     6 months 52.17 (10.21) 52.46 (9.54) 
    12 months 55.63 (5.89) 53.06 (8.74) 
SCL-90 Anxiety 
0.11 0.06 0.51     2 months 0.38 (0.34) 0.57 (0.62)     6 months 0.40 (0.37) 0.49 (0.49) 
    12 months 0.31 (0.34) 0.39 (0.39) 
SCL-90 Depression 
0.24 0.23 0.85     2 months 0.55 (0.51) 0.67 (0.65) 6 months 0.58 (0.60) 0.66 (0.48) 
    12 months 0.45 (0.30) 0.59 (0.42) 
Note: SF-36: Short Form-36; PCS: Physical Component Summary; MCS: Mental Component Summary; 
SCL-90: Symptom Checklist-90. 
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4.5 DISCUSSION 
This study employed trajectory modeling to examine patterns and correlates of adherence to self-
monitoring over the first year after discharge from transplant hospitalization.  Findings revealed 
two distinct patterns of adherence to self-monitoring, namely persistently nonadherent and 
moderately adherent with slow decline and identified several baseline and longitudinal correlates 
associated with predicted trajectory group membership. 
Having lower internal health locus of control beliefs at baseline was a significant correlate 
of membership in the persistently nonadherent group, which is consistent with findings of Dew et 
al. (2008) that having a weaker belief that one’s own actions influenced health outcomes increased 
the odds of being persistently nonadherent to performing spirometry. While the mean score of 
internal health locus of control for our overall sample is comparable to that in previous reports 
(DeVito Dabbs, Kim, Hamdan-Mansour, Thibodeau, & McCurry, 2006; Lindgren et al., 2002), 
our results showed that the persistently nonadherent group possessed a significantly lower internal 
health locus of control than the moderately adherent group, suggesting that clinicians should 
encourage LTRs to play an active role and reinforce the importance of taking personal 
responsibility in post-transplant care management.  
Our results demonstrated that poorer ratings of the physical health component of quality of 
life were associated with the membership in the persistently nonadherent group over the 12-
months post-discharge. This is consistent with findings of previous qualitative evidence that 
reported LTRs’ views that their perceived poor physical health is a major barrier for adherence to 
self-monitoring of lung function (Kugler, Gottlieb, et al., 2010; Sabati, Snyder, Edin-Stibbe, et al., 
2001). We also found that endorsing a higher anxiety level was associated with being persistently 
nonadherent. The negative association between psychological distress and 1) self-care agency, 2) 
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adherence behaviors and 3) transplant-related health outcomes among LTRs and other solid organ 
recipients has been well-established (Barbour, Blumenthal, & Palmer, 2006; DeVito Dabbs, 
Terhorst, Song, et al., 2013; Dew & DiMartini, 2005; Dew et al., 2012, 2015; Rosenberger et al., 
2012). Clinicians can apply this evidence to identify LTRs with higher physical and psychological 
burden and intervene to directly address these perceptions and potentially promote better self-
monitoring and better outcomes.  
We found that female LTRs were at increased risk of being in the persistently nonadherent 
group. Being female has also been found to be a significant predictor of nonadherence to home 
spirometry by Dew and colleagues (2008). While the reason for this finding has not been well 
examined, it is possible that female LTRs may have more competing priorities with self-
management (Manteuffel et al., 2014), which lead to limited attention to their own health issues, 
and thus, lower adherence. These findings suggest that clinicians may need to identify unique 
barriers to adherence among female LTRs and monitor their adherence more closely after 
discharge. 
Two distinct adherence patterns were identified in this current study, moderately adherent 
with slow decline and persistently nonadherent. Although the moderately adherent group 
demonstrated better adherence to self-monitoring than the persistently nonadherent group, the 
adherence level declined over time in both groups. This decline in adherence behavior has been 
repeatedly observed in prior studies (De Geest et al., 2014; Dew, DiMartini, et al., 2008). In 
addition, our results showed that even with the better adherence group, they only started with 
moderate level of 63.84% adherence to self-monitoring at 2-months post-discharge. This together 
suggests that adherence to self-monitoring is a problematic issue and continues to be challenging 
in LTRs. Clinicians may need to reinforce the importance of self-monitoring and regularly check 
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LTRs’ adherence to self-monitoring during their clinical follow up visits. This also points to a 
pressing need for more intervention studies to explore effective strategies to promote and sustain 
adherence to self-monitoring in LTRs.   
 
Limitations 
 This study has several limitations. As a secondary analysis of data from a completed study, 
we were unable to collect data for additional variables that may have influenced adherence to self-
monitoring, such as patient’s beliefs about self-monitoring. Also, some variables, such as the 
quality of the relationship with caregiver and health locus of control beliefs were only measured 
at baseline, limiting our ability to examine them as longitudinal correlates of adherence to self-
monitoring. Because our aim was to describe the natural course of adherence to self-monitoring 
over the first year post-transplant, we only studied LTRs randomized to the usual care arm of the 
parent study, which provided a relatively small sample size for this analysis. However, we did 
employ several approaches (e.g., we screened univariate relationships first to identify candidate 
correlates (p<0.30) in the multivariate models, and used backward elimination to reach a most 
parsimonious model) which permitted us to meet the recommended case-to-variable ratio of 10:1 
(Tabachnick & Fidell, 2007). Also, we relied on paper logs as a proxy measure of self-monitoring, 
which may have underestimated adherence because participants may have performed self-
monitoring but not necessarily documented on the paper log. In addition, we used a global measure 
of self-monitoring, that is self-monitoring of any health indicator (i.e., lung function, vital signs, 
symptoms), yet this global measure of self-monitoring has been reported and used often in the 
literature (Adam et al., 2007; DeVito Dabbs et al., 2009; Finkelstein et al., 2013; Mullan et al., 
2003; Wang et al., 2013). This study was conducted at only one transplant center which may have 
  70 
limited the generalizability; however, the characteristics of our sample were representative of the 
United States samples (Organ Procurement and Transplantation Network, 2012). Despite its 
limitations, this study demonstrated the application of group-based trajectory modeling to the study 
of adherence behaviors in LTRs and is among the first study to explore the associations between 
longitudinal covariates and adherence behaviors over time, which could inform the design of future 
interventions.  
4.6 CONCLUSIONS  
Promoting adherence to self-monitoring could improve early detection and treatment of 
complications and thus optimize health outcomes for LTRs. Our findings suggested two distinct 
patterns of adherence to self-monitoring and pointed to several modifiable targets for interventions 
to promote adherence to self-monitoring among LTRs, such as reducing post-transplant anxiety, 
and strengthening the sense of personal control over health. Findings also suggest clinicians should 
target LTR who is female or has poor physical health as high-risk population for poor adherence 
to self-monitoring.  
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5.0  SUMMARY OF DISSERTATION FINDINGS 
This dissertation project consists of 3 complementary studies to address several gaps in the 
scientific literature on adherence to the medical regimen following lung transplantation. Findings 
are documented in the following three manuscripts:  
Manuscript #1: Nonadherence to the Medical Regimen after Lung Transplantation: A 
Systematic Review; 
Manuscript #2: Patterns and Correlates of Self-Care Agency in Lung Transplant 
Recipients over the First 12-months Post-Hospital Discharge Following Transplantation; and 
Manuscript #3: Patterns and Correlates of Adherence to Self-Monitoring in Lung 
Transplant Recipients over the First 12-months Post-Hospital Discharge Following 
Transplantation. 
 
Although each of these three manuscripts had a distinct purpose, viewing their findings 
together reveals several key messages. First, nonadherence to post-transplant medical regimen 
is a complex and prevalent issue among LTRs. The complex nature of nonadherence was 
reflected in our systematic review (manuscript 1), which revealed that nonadherence rates varied 
greatly across studies and between different elements of the post-transplant medical regimen and 
could not be attributed to any specific factor. Findings of manuscript 3 confirmed that adherence 
to self-monitoring, in particular, was challenging and less than ideal among LTRs. Although the 
use of trajectory modeling helped to identify two distinct trajectory groups for adherence to self-
monitoring, with one group maintaining a relatively higher level of adherence than the other group, 
adherence declined in both groups over the first 12-months post-discharge following transplant. 
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Indeed, the moderately adherent group maintained only 32% adherence to self-monitoring at the 
end of first-year. Taken together, these alarming findings affirm previous reports that 
nonadherence continues to be a challenging and prevalent issue among LTRs.  
Evidence suggests that LTRs may stop self-monitoring because they failed to perceive a 
need to do so when their transplant care providers stopped reviewing the logs of their self-
monitoring readings after the first few follow up visits (Dew et al., 2008). This highlights the 
critical role that clinicians play in promoting adherence to self-monitoring and the importance of 
empowering LTRs. Some examples of patient empowerment for clinicians to consider include: 
helping LTRs to establish the habits of self-monitoring during transplant hospitalization, 
reinforcing the importance of the patient’s important role in ongoing self-monitoring, reviewing 
self-monitoring logs at follow up visits to emphasize the value of self-monitoring, and asking about 
and addressing barriers LTRs face in performing self-monitoring.  
Another key message from this dissertation work is that psychological distress is an 
important factor in post-transplant care of LTRs. Our findings showed that higher levels of 
psychological distress were associated with both lower self-care agency (SCA) (manuscript 2) and 
being persistently nonadherent to self-monitoring (manuscript 3). It must be acknowledged that 
these are associations and not causal relationships. Specifically, it is plausible that psychological 
distress leads to lower SCA, but it is also plausible that individuals with lower SCA are more 
susceptible to psychological distress. While sychological distress may contribute to poorer 
adherence behaviors, the demands of adherence to a complex medical regimen may also lead to 
psychological distress. Regardless of the direction of these relationships, there is a case to be made 
for identifying and addressing psychological distress among LTRs. Given the clinical importance 
and high incidence rate of psychiatric disorders (reaching up to 30% in LTRs) (Dew et al., 2012), 
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transplant care teams should consider screening and treating psychological distress as one of major 
priorities in post-transplant care. Clinicians should identify those high-risk populations and 
intervene to help psychologically distressed individuals, which may include exploring and 
addressing the role of SCA or demands of the medical regimen, with the goal of ultimately 
positively impacting health outcomes among LTRs.  
Lastly, our findings revealed several other targets for promoting SCA and adherence 
behaviors among LTRs. Findings from manuscript 3 suggested that having a weaker sense of 
control over one’s own health (internality health locus of control) significantly increased the odds 
of being in the persistently nonadherent group. This points to the need to educate, encourage, and 
empower LTRs to take a more active role in their post-transplant care. Some strategies for patient 
empowerment have been mentioned above. In addition, we also found that poorer physical health 
status was associated with lower SCA (manuscript 2) and being persistently nonadherent to self-
monitoring (manuscript 3). Given that poor physical health status may pose a health threat to LTRs, 
it is important for clinicians and researchers to engage family members more in the post-transplant 
care for LTRs who are struggling with poor health.  
In conclusion, this dissertation provided an overview of the current state of science 
regarding adherence behaviors among LTRs and specifically explored adherence to self-
monitoring and self-care agency among LTRs over the first 12-months post-discharge from 
transplantation. Knowledge obtained from this dissertation work suggests future research studies 
should explore the following issues:  
1) Descriptive studies are needed to explore the clinically meaningful level of adherence 
to self-monitoring after lung transplantation.  
2) Future intervention research on promoting adherence among LTRs should test theory-
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driven strategies and consider assessing and reducing distress, and reinforcing sense of 
control over one’s own health as components of their interventions. In addition, future 
interventions should also explore how to leverage current technologies to better 
measure and promote adherence among LTRs.  
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